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ABSTRACT

Toxoplasma gondii is an intracellular parasite o f humans in the phylum
Apicomplexa. In an intermediate host (including human and other mammals), T. gondii
occurs in an actively dividing form (tachyzoite) and a dormant form (bradyzoite). My
research is focused on the function o f enolase, which is present in two isoforms known as
ENOl and EN 02. Previous study showed that enolase is expressed in stage-specific
manner. EN 02 is expressed only in tachyzoites, and ENOl is specifically expressed in
bradyzoites. Moreover, both isoforms o f enolase are be localized in nucleus as well as in
cytoplasm o f T. gondii. This research is aimed to dissect the role o f E N 02 in the growth
o f T. gondii. I used homologous dsRNA to induce ENOl or E N 02 gene silencing. I
generated two transgenic parasite lines expressing ENOl or E N 02 dsRNA, and used
them in the loss-of-function study. Although the reduction o f EN 02 expression was
observed, I did not detect any changes in the growth o f parasites, as monitored by two
different methods, vacuole counting and plaque assay. I postulated that another protein or
other metabolic pathway might compensate for the loss o f E N 02 function.
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CHAPTER 1
INTRODUCTION
1.1 Toxoplasma gondii
Toxoplasma gondii is an intracellular pathogenic protozoa parasite. It belongs to
the phylum Apicomplexa and is the only known member o f the genus Toxoplasma. It was
first discovered in a rabbit, by Splendore in Brazil in 1908, and also by Nicolle and
Manceaux in a northern African rodent Ctenodactylus gundi (Black and Boothroyd,
2000). As most o f the Apicomplexa parasites, T. gondii is an important pathogenic agent
of humans and animals. Its hosts include the vast majority o f warm-blooded animals. In
2000, it was reported that, 15.8% o f the population between 12 to 49 years old in United
States were infected with T. gondii (Jones et ah, 2003). The infection causes the disease
called toxoplasmosis, which is usually asymptomatic in healthy individuals. However, for
immuno-compromised patients, such as AIDS patients and those who have recently
received organ transplantation, infection by T. gondii can cause severe complications
such as hepatitis, pneumonia, blindness, and neurological disorders and may lead to
behavioral alteration. Furthermore, an acute infection during pregnancy can cause in
utero infection as well, resulting in a spontaneous abortion, a stillborn child, or a child
that is bom with some degree o f mental or physical retardation (Dubey, 1996).
While residing in the hosts, T. gondii converts between tachyzoite, the rapid
proliferating

stage,

and

bradyzoite,

the

slowly

replicating

stage.

Normally,

uncompromised host immune response can quickly remove tachyzoites during the acute

l
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infection. In most cases of human toxoplasmosis, tachyzoites can differentiate into
bradyzoites, which stay within the tissue cysts. Parasites are thus able to escape the host
immune response for the remainder o f the host’s lifespan, leading to the chronic infection.
When the patients become immuno-compromised, bradyzoites are released from the cysts
and differentiate into tachyzoites, resulting in a recurrent acute infection (Gross et al.,
1996).

Current

treatment

o f toxoplasmosis

using

a

cocktail

o f pulfonamide

(dihydropteroate synthetase inhibitor) and pyrimethamine (dihydrofolate reductase
inhibitor) is only effective for the acute infection and may cause harsh side effects (Black
and Boothroyd, 2000). Although a combination o f atovaquone and clindamycin is
effective for treatment o f the chronic toxoplasmosis in mouse and some other animals,
their effects have not been

re-produced

in human

(Alves

and Vitor, 2005;

Djurkovic-Djakovic et al., 2002). To develop new drug targets and strategies to eradicate
its infection, we need to learn more about the parasite, especially its metabolism and
interaction with host organisms.

1.1.1 Life cycle o f T. gondii
Toxoplasma gondii multiplies by sexual and asexual cycles. The sexual life cycle
occurs exclusively in the intestine o f its definite host, felines. The cycle begins when a cat
ingests food containing T. gondii-tissue cysts. The parasites are released from the cyst in
the small intestine and infect epithelial cells, initiating gametogenesis and differentiation
into micro- and macrogametes. Then, two gametes fuse and produce an oocyst, which is

2
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later secreted in feces. Millions o f oocysts can be generated within 2 weeks after oocyst
formation. Within 2-3 days after being released from the intestine, oocysts undergo
sporogony and generate the infective haploid stage known as sporozoites. The mature
sporozoites are very stable in the environment and can survive for months in cold and dry
climates (Dubey, 1994). When the sporozoites are ingested by the felines, they continue
to propagate by the sexual life cycle. Ingested by other animals, referred to intermediate
hosts, the parasites will multiply using their asexual life cycle.
The asexual life cycle occurs in any infected warm-blooded animals. The
transmission can usually begin following the ingestion o f sporulated oocysts or
bradyzoites in tissues cysts in raw or contaminated meat products. Then the parasites
transform into tachyzoites and reproduce asexually within infected cells. After several
rounds o f synchronous division o f the parasites, the infected cells that cannot support the
parasite load will be destroyed. Newly formed tachyzoites are then released to infect
other cells. During this phase o f infection, the tachyzoites can spread to every organ of
the host. Approximately 2-3 weeks following infection and in response to the host
immunity, the tachyzoites convert to slow-replicating bradyzoites within the tissue cysts
(Dubey et al., 1998; Soete et al., 1993).

3
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Figure 1.1
Life cycle of Toxoplasma gondii
Legend
The life cycle of T. gondii consists o f two phases: sexual and asexual. The sexual
phase occurs only in the intestine o f felines (definite host) while the asexual phase takes
place in birds and animals (Yang and Parmley, 1997). The figure is obtained from Black
and Boothroyd, 2000.

4
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Figure 1.1
Life cycle of Toxoplasma gondii
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1.1.2 Differences between tachyzoites and bradyzoites
The conversion between tachyzoites
morphological

and molecular biological

and bradyzoites
changes,

including

is accompanied by
the

expression

of

stage-specific antigen and the alterations o f basal metabolism (Ferguson and Hutchison,
1987; Denton et al., 1996).
The fast-growing tachyzoite is usually surrounded by a sac-like membrane, called a
parasitophorous vacuole, which originates from both the host and parasite cell
membranes (Gross et al., 1996). The tachyzoites within a single vacuole usually divide
synchronously, leading to the formation o f a rosette structure. The bradyzoites stay in the
tissue cysts that can be as large as 100pm in length and are mainly localized in the brain
and muscle tissues. The tissue cysts are surrounded by an elastic thin wall which contains
P-(l, 4) linkaged N-acetyl-glucosamine residues called chitin without glycogen and other
polysaccharides (Gross et al., 1996). The cyst wall is able to bind with lectins such as
those found in the seed o f Dolichos biflorus and wheat-germ (Boothroyd et al., 1997;
Tomavo, 2001; Cleary et al., 2002). Thus these lectins are used as the detection reagents
for the tissue cysts and bradyzoites (Ferguson et al., 2002). Within the cyst wall, the
bradyzoites are less susceptible proteolytic enzymes and gastric acid in the stomach
(Freyre, 1995). Within the cytosol o f the bradyzoites, several amylopectin granules are
located and supposedly act as energy source. Having non-functional mitochondria,
bradyzoites lack a functional TCA cycle and respiratory chain. As a result, bradyzoites
are not susceptible to mitochondrion electron transport inhibitors such as atovaquone. On

6
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the other hand, tachyzoites have functional mitochondria and both aerobic and anaerobic
respiration (Denton et al., 1996; Dando et al., 2001). Thus glycolysis is essential for both
tachyzoites and bradyzoites. Therefore, the enzymes catalyzing the reactions in the
glycolysis

pathway,

such

as

enolase,

glucose-6-phosphate

isomerases

and

glyceraldehyde-3-phosphate dehydrogenase, have been considered as promising drug
targets in T. gondii and many other apicomplexa parasites (Verlinde et al., 2001; Roos,
2005).
Differential expressions of heat shock proteins (HSP) were reported in the
tachyzoite and bradyzoite stages. For example, two differentially spliced forms o f HSP60
are present in both life cycle stages. Using polyclonal antibodies raised against HSP60, it
was found that HSP60 is localized in the mitochondria in tachyzoite stage, while in two
vesicular bodies during the stage o f bradyzoites (Toursel et al., 2000). Bradyzoite specific
antigen 1 (BAG1) or HSP30, which is homologous to small plant HSP, is only expressed
in bradyzoites, but not in tachyzoites (Bohne and Roos, 1997; Parmley et al., 1995). In
addition, many surface antigens, including CST1, SAG2A and SAG2B, are stage-specific,
suggesting they might be important for the interaction between the parasites and their
host cells (Zhang et al., 2001; Cleary et al., 2002; Lekutis et al., 2000). Moreover, a
number o f metabolic enzymes, including those o f glycolysis and gluconeogenesis such as
lactate dehydrogenase (Dando et al., 2001), glucose-6-phosphate isomerases (G6PI) and
enolase (ENO), were reported to be differentially expressed in tachyzoite and bradyzoite,
suggesting that their association with changes in metabolism rates and environment

7
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adaptation o f the parasites (Yang and Parmley, 1997; Tomavo, 2001; Dzierszinski et al.,
2001; Dzierszinski et al., 1999).

1.1.3 Interconversion between tachyzoite and bradyzoite
The conversion between tachyzoite and bradyzoite is essential for T. gondii and
plays a key role in its pathogenesis. A better understanding o f the interconversion
mechanism could greatly facilitate a design for new chemotherapeutic agents capable of
eliminating tissue cysts (Boothroyd et al., 1997). In vivo, the stage conversion is related
to the host inmmune responses. It has been suggested that the switch between tachyzoites
and bradyzoites is related to the expression o f heat shock proteins and parasites’ stress
responses.
Most experimental strains o f T. gondii can switch between tachyzoites and
bradyzoites in cell cultures. About 10-20% o f cysts are formed by spontaneous
conversion. External stresses mimicking the host immune responses can induce tissue
cyst formation and increase the formation o f cyst in vitro (Soete et al., 1993). The
cyst-induction includes growing the parasites in the alkaline environment (pH 8.2-8.4) or
acid conditions (pH 6.6-6.8), increasing culture temperature (42 °C instead o f 37 °C).
These methods rely on the stress response o f the parasites (Soete et al., 1993; Weiss et al.,
1995; Weiss and Kim, 2000).

Inhibitors o f mitochondrial function, such as oligomycin,

antimycin A, atovaquone and rotenone, as well as inducers o f oxidative stress including
nitric oxide and Nitroprusside, an exogenous source o f nitric oxide, can also induce the
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encystment of in vitro cultures (Soete et al., 1993; Bohne et al., 1994).

It was also

shown that the elevation o f cAMP or cGMP could play a role in the bradyzoite induction
(Kirkman et al., 2001). Immunological factors, including interferon (IFN)-y and tumour
necrosis factor (TNF)-a, play a role in controlling tachyzoite growth and could indirectly
control stage conversion. Although evidence suggest the indirect effect o f NO-induced
stress, the underlining mechanism has yet been determined (Alexander and Hunter,
1998).
Additionally, it was reported that conditions favouring the formation o f bradyzoites
were associated with the up-regulation o f heat shock proteins (HSPs), suggesting that
HSPs are essential during stress-induced stage conversion (Weiss et al., 1998). Knockout
o f the BAG1 {HSP30) gene can decrease, but not completely prevent in vivo cyst
formation o f the parasites. This evidence further validates the involvement o f HSPs in the
process o f stage conversion (Bohne et al., 1998).

1.1.4 T. gondii culture conditions and parasite strains
Toxoplasma gondii can be in vitro cultured in different cell types. Human foreskin
fibroblasts (HFF) are the most widely used because they quickly propagate and survive in
the presence of many growth-inhibiting drugs, such as those used during the selection of
transgenic parasites. Additionally, they allow the parasites to replicate for several cycles
before lysis (Freyre, 1995; Roos et al., 1994). Various cell cultures, namely Vero cells,

9

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Hela cells and T cells, are commonly used in the culture of T. gondii (Cleary et al., 2002;
Boothroyd et al., 1997).
There are several experimental strains o f T. gondii. Each strain exhibits different
replication rates, virulence and ability to form in vitro cysts and are thus suitable for
different experimental design (Freyre, 1995). An experimental strain called RH is highly
virulent and fast-duplicating and the most commonly used in biochemical experiments,
particularly in the characterization o f parasite virulence and production drug-resistant
mutant lines (Roos et a l, 1994). However, the RH strain exhibits less ability to form
tissue-cysts, thus produces few tissue cysts in mouse when cultured in vitro. Moreover
the RH strain can not undergo the sexual replication in the definite hosts (Freyre, 1995).
Other strains, such as ME49 produce more tissue cysts and are thus ideal for study on
bradyzoite development and differentiation. A subclone o f ME49 strain, referred to as the
PLK strain, shows slower replicating rates and is widely used for the study o f life cycle
and stage conversion o f T. gondii, due to its ability to undergo complete sexual life cycle
and to convert between tachyzoites and brayzoites (Soete et al., 1993; Boothroyd et al.,
1997).

1.1.5 T. gondii as an experimental model for apicomplexan parasites
Many members o f Apicomplexa are pathogenic. For example, Plasmodium
falciparum is the causing agent o f malaria. It is difficult to culture and maintain in the
laboratory, thus impeding the experimental studies (Sibley, 2003). T. gondii, on the other
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hand, can be easily maintained in vitro using standard cell culture techniques. In addition,
this parasite is amenable for molecular transformation and is thus ideal for genetic
manipulation and analysis. Genetic manipulation by molecular transformation, including
both transient transformation and stable transformation, has been widely employed as a
tool to verify gene function and molecular events at various stages o f T. gondii (Kim and
Weiss, 2004). The modulations o f T. gondii gene expressions by molecular tools such as
insertional mutagenesis, tetracycline-repressor-based inducible systems, are extensively
utilized to analyze gene functions (Donald and Roos, 1995; Nakaar et al., 2000; Meissner
et al., 2001). T. gondii has an 80 Mb haploid genome consisting o f 14 chromosomes
during its asexual life cycle, which facilitates the generation o f loss-of-function mutants
(Black and Boothroyd, 1998; Khan et al., 2005). Additionally, most o f the genome
sequence o f T. gondii has been revealed (ToxoDB, http://www.toxodb.org, (Kissinger et
al., 2003). Several genes of T. gondii are representive of related genes found in other
related Apicomplexans. Thus this parasite is widely used as an experimental model (Roos
et al., 1994; Black and Boothroyd, 2000; Kim and Weiss, 2004).

1.1.6 Genetic manipulation of T. gondii
1.1.6.1 Transient and stable transformation
The development o f molecular transformation o f T. gondii has made genetic
manipulation a highly employed tool to study gene functions and molecular events o f the
parasites. Electroporation, introducing exogenous DNA or RNA into cells by the pulse of
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current, is the most efficient technique to introduce nucleic acids into T. gondii. In
transient transformation, several reporter genes such as P-galactosidase (LacZ) and
chloramphenicol acetyltransferase (CAT) have been successfully employed. Their
expressions are efficient when driven by T. gondii promoters such as those o f the major
surface antigen (Lekutis et al., 2000), the rhoptry protein (Soldati et al., 1995) and the
P-tubulin (TUB1) (Roos et al., 1994; Soldati et al., 1995)
Stable transformation, resulting in the generation o f parasite lines that permanently
express transgenes by directed (homologous) or random integration (non-homologues
recombinants) into the parasite genome, has widely been used (Donald and Roos, 1994).
Moreover, Black and Boothroyd (1998) developed an episomal vector, which is able to
replicate autonomously in T. gondii without integrating into the genome. They found that,
when they randomly used DNA fragments isolated from the Toxoplasma genomic DNA
to construct into transforming plasmids, some o f these sequences permit the episomal
maintenance o f the plasmid in the parasites. These episomal vectors avoid the possibility
of introducing mutations into the genome by non-homologous recombination. Episomal
vectors also offer the advantage o f allowing easy analysis o f the activity attributed to the
transformed DNA. This is accomplished by isolating the episome to re-transform the
parental strain or by selecting against the episom e using a negative selectable marker. The

development o f this molecule tool may help to understand the events critical to T. gondii
such as invasion, intracellular replication, and differentiation (Black and Boothroyd,
1998).
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1.1.6.2 Selectable markers for stable transformation
Selectable markers are required for gene transformation that cannot be selected
directly. Two non-essential enzymes involved in the nucleotide pathways o f T. gondii,
uracil

phosphoribosyl

transferase

(Al-Anouti

et

a l,

2003)

and

hypoxanthine-xanthine-guanine phosphoribosyl transferase (HXGPRT), as well as other
enzymes

like

dihydrofolate

reductase-thymidylate

synthase

(DHFR-TS)

and

chloramphenicol acetyltransferase (CAT) are utilized efficiently as the selectable markers
for T. gondii transformation (Donald and Roos, 1994).
HXGPRT is important for the purine salvage pathway o f T. gondii. It catalyzes the
conversion from hypoxanthine, xanthine, and guanine into inosine monophosphate (IMP),
xanthosine monophosphate (XMP) and guanine monophosphate (GMP) respectively.
XMP can be further utilized for the synthesis o f GMP, and can also be generated from
IMP by IMP dehydrogenase in the absence o f xanthine or HXGPRT (Fig. 1.2). HXGPRT
can

also

catalyze

the

conversion

from

6-thioxanthine

(6-TX)

to

6-thioxanthosine-5'-phosphate, which is toxic to the parasites. However, 6-TX cannot be
recognized by mammalian host cells that lack the XPRT activity. Thus HXGPRT can be
utilized as a negative selectable marker using 6-TX as the selection (Chaudhary et al.,
2004; Donald et al., 1996). The generation o f HXGPRT knockout T. gondii strains (RHA
HXGPRT, FLKAHXGPRT) makes it possible to use HXGPRT as a positive selectable
marker for molecular transformation. The positive selection requires the existence of
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mycophenic acid (MPA) and xanthine. MPA inhibits the activity o f IMP dehydrogenase
and thus prevents the formation o f XMP and subsequent GMP, which is essential for T.
gondii survival using this pathway. Parasites with HXGPRT expression can utilize
HXGPRT to generate XMP from xanthine and maintain their lives, while those without
HXGPRT expression would be killed (Donald et al., 1996). The H XGPRT knockout
strains can be used in transformation with plasmids that express HXGPRT and the
medium supplemented with MPA and xanthine is effective to select transformed parasites
from those without.
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Figure 1.2
Purine Salvage Pathway of Toxoplasma gondii
Legend

Schematic representation o f purine salvage pathway o f T. gondii. Enzymes are indicated
by arrows labeled AK (adenosine kinase), HXGPRT, or with numbers in the Toxoplasma
panel (unless otherwise indicated): 1, adenosine deaminase; 2, purine nucleoside
phosphorylase; 3, adenine deaminase; 4, AMP deaminase; 5, IMP dehydrogenase
(inhibition target o f MPA); 6, GMP synthetase; 7, adenylosuccinate synthetase; 8,
adenylosuccinate lyase. HC, host cell cytoplasm; PV, parasitophorous vacuole; PC,
protist cytoplasm (Chaudhary et al., 2004).
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Figure 1.2
Purine Salvage Pathway o f Toxoplasma gondii
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1.1.6.3 RNA tools in T.gondii
RNA tools, including ribozyme and antisese RNA, have been used for the
down-regulation o f gene expression in many organisms including T. gondii (Al-Anouti
and Ananvoranich, 2002; Sheng et al., 2004; Nakaar et al., 2000; Nakaar et al., 1999).
They are efficient for the study on essential genes functions, because these RNA tools
have the advantage that they do not disrupt gene expression at the DNA level as the DNA
transformation (Lamond and Sproat, 1993). Moreover, these RNA tools can be used in
suppressing gene expression and in phenotypic studies.
Antisense RNA functions by base-pairing with target mRNA to interrupt the
downstream process (i.e. translation) or by destroying the target mRNA by RNase H
(Lamond and Sproat, 1993; Hostomsky et al., 1994). It was employed to modify the
expression o f triphosphoate hydrolase (NTPase) as well as HXGPRT in T. gondii (Nakaar
et a l, 1999). Ribozyme, first discovered by Cech and Altman in the 1980s, are RNA
molecules that can catalyze RNA cleavage in a site-specific manner (Tanner, 1999). In T.
gondii, engineered delta ribozymes were successfully utilized to reduce the expression of
UPRT and HXGPRT (Sheng et al., 2004).
RNA interference (RNAi), an endogenous machinery o f gene regulation, is
functional in many eukaryotic organisms (Hannon, 2002; Fire et ah, 1998). In T. gondii,
when dsRNA homologous to UPRT is introduced into the parasites, the expression level
of UPRT is lowered (Al-Anouti et al., 2003). The efficacies in gene silencing o f dsRNA
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and delta ribozyme are similar and are much higher than that o f antisense RNA
(Al-Anouti and Ananvoranich, 2002).

1.2 Enolase
Enolase

(2 phospho-D-glycerate

hydrolase,

EC 4.2.1.11)

is

a glycolytic

metal-activated enzyme. It belongs to the enolase superfamily comprising among other
carboxyphosphonoenolpyruvate synthase. The enzyme catalyzes the Mg2+-dependent
removal

of

one

water

molecule

from

2-phosphoglycerate

(2PGA)

to

yield

phosphoenolpyruvate (PEP), the penultimate step in the conversion o f glucose to
pyruvate. This reaction step is the only dehydration reaction in the glycolysis pathway.
Moreover,

enolase also

catalyzes

the

reverse reaction

during the process

of

gluconeogenesis. This glycolytic enzyme usually exists as a dimer o f 45-48 kDa subunits,
in which one magnesium ion is required for each subunit (Lebioda and Stec, 1991).
Moreover, this enzyme is found to be highly conserved among different species from
archaebacteria to mammals.

1.2.1 Enolase isoforms in T. gondii
In T. gondii, two isoforms o f enolases are known as EN O l and EN 02. Genes
encoding these two enolase isoforms, showing 65.8% in open reading frame (ORF)
nucleotide sequence identity, are localized on Chromosome VIII o f T. gondii, residing
closely to each other. ENOl and E N 02 exhibit 73.8% amino acid similarity. ENOl is
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expressed only in bradyzoites and EN 02 is specifically expressed in tachyzoites.
Compared to enolases from other organisms, the T. gondii enolase isoforms carry a
pentapeptide EWGY(W)S(C) (103-107 aa) insertion and a dipeptide E(D)K (263 and 264
aa) and are thus considered highly related to those o f plants (Dzierszinski et al., 1999).
During differentiation between tachyzoites and bradyzoites, enolase is important for
glycolysis and anaerobic respiration. It has thus been hypothesized that EN O l and EN 02
might be a promising target for developing drugs for chronic toxoplasmosis.
Comparing characterizations o f these two enolase isoforms using recombinant
proteins, it was found that ENOl and EN 02 exhibit similar kinetic parameters: Michaelis
constant (Kirkman et al., 2001) o f 76.8pM vs. 77.7pM. However, EN 02 had threefold
higher specific activity ( Vmax - 89.2 mmol x m in'1 x m g'1) than EN O l (Fmax. = 34.1 mmol
x m in'1 x m g'1). Both isoforms have a similar optimum pH at pH 7.2. But ENOl is
slightly more stable than EN 02. The denaturation temperature o f EN O l was estimated at
64.0 °C, while that o f EN 02 at 57.0 °C (Dzierszinski et al., 2001). The different
expression patterns as well as different enzymatic characterizations o f EN O l and EN 02
suggest that these two isoforms might be related to the different metabolism rates o f
tachyzoites and bradyzoites. E N 02, which is more active and less stable, is expressed
only in the virulent tachyzoite stage, supposedly important for rapid development. EN O l,
less active but more stable than EN 02, is more suitable for the encysted dormant
bradyzoite with less energetic requirements. ENOl and EN 02 are distinct in their
antigenic properties. The polyclonal antibodies raised against ENOl do not cross-react
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with E N 02, vice versa, despite the high degree o f amino acid homology (Dzierszinski et
al., 2001). It hypothesized that the difference in the expression pattern o f enolase
isoforms, as well as other stage-specific metabolism enzymes such as LDH and GP6I, is
necessary for environmental adaptation and metabolic requirements o f the two different
parasitic stages. However, little is known about how the expressions o f these stage
specific enzymes are regulated during the stage conversion.

1.2.2 Structural features of enolase
Similar to enolases in other organisms, the two enolase isoforms o f T. gondii
contain conserved amino acid residues important for their catalytic activity. As indicated
in Figure 1.3, these amino acids are G lul74, Glu217 and Lys355, which are involved in
the dehydratation step; Asp252, Glu303 and Asp330, whose carboxylate groups
coordinate the conformational metal ion ligand (Mg2+) required for substrate binding;
Arg384 interacting with the phosphate group o f 2-PGA; and His383 and Lys406
interacting with the carboxylic group o f 2-PGA (Dzierszinski et al., 2001; Lebioda et al.,
1989; Lebioda and Stec, 1991). The different characterization o f EN O l and EN 02 might
be due to the difference in the residues surrounding or neighboring those residues directly
involved in the substrate binding or catalysis.
The deletion o f the two plant-like motifs in ENOl decreases its activity
(Dzierszinski et al., 2001). These two plant-like peptide insertions are positioned in
highly conserved regions. The dipeptide insertion localized on the amino acids 263 and
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264 aa is in one o f the connection loops intruding into the active site o f EN 02 and EN O l.
The pentapeptide insertion found at position 103-107 aa increases the length o f a
connecting loop in the C-terminal domain and makes it close to the active site o f the
enzyme. These structural features provide possible explanation to the significance of
these two insertions in the activity o f enzyme. These plant-like motifs are also found in
enolase o f Plasmodium falciparum, another member o f Apicomplexa family (Read et al.,
1994). This feature may suggest that Apicomplexa and plants are derived from a common
ancestor, or Apicomplexa acquired their enolase by an endosymbiotic gene transfer from
the cyanobacterial ancestors o f the green algal plastid in their cytosol.
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Figure 1.3
Sequence Alignment of EN O l and E N 02
Legend

The amino acid sequnce o f T. gondii ENOl and EN 02 is aligned using LALIGN
program

(http://www.ch.embnet.org/software/LALIGN form.htmQ.

Two

plant-like

motifs (103-107 aa EW G Y (W )S(C), 263 and 264 aa E(D)K) are shown in green colour.
And conserved amino acids (G lul74, Glu217, Asp252, Glu303, Asp330, Lys355, His383,
Arg384 and Lys406) important for catalytic activity are shown in red colour
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Figure 1.3
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1.2.3 Multiple functions of enolase
As a glycolytic enzyme, enolases localize in the cytoplasm, where they can be free
or easy to associate with the cytoskeleton and other glycolytic enzymes. In T. gondii,
EN O l and EN 02 are localized in the cytoplasm and nuclei, although there is no classic
nuclear localization signal found in their amino acid sequences (Ferguson et a l, 2002).
This discovery suggests that, T. gondii enolase might have some additional functions,
such as nuclear activities (i.e. division) and regulation o f gene expression.
In other organisms, enolase has also been reported to perform multiple functions.
For example, a-enolase, one o f the three isoforms o f enolase found in animals, is
identified as the eye lens crystallin in reptiles and birds (Piatigorsky and Wistow, 1989).
In HeLa cells, a-enolase acts as a component o f the centrosome, and one o f its alternative
transcript products known as rayoprom oter binding protein 1 (Feo et a l, 2000) can bind
to c-myc promoter and negatively regulate transcription o f this protooncogene (Johnstone
et al., 1992; Ghosh et al., 1999). In human peripheral blood cells, a-enolase functions as a
plasminogen receptor (Redlitz et a l, 1995), and is one o f the hypoxia-inducible proteins
(Semenza et a l, 1996). In fusion yeast Saccharomyces cerevisiae, enolase is the heat
shock protein HSP48 and involved in thermal tolerance and growth control in this
organism. Thus yeast enolase is recruited as a cofactor o f tRNA targeting toward
mitochondria (Iida and Yahara, 1985).
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Apart from their metabolitic functions, it is not yet known whether T. gondii
enolase isoforms have additional functions. One o f the focuses o f this study is to reveal
the physiological functions o f ENOl and E N 02 in the development o f T. gondii.

1.3 Gene silencing in T. gondii
In order to study the roles o f EN 02 in T. gondii, I chose to suppress or silence the
expression o f EN 02

in the parasites. Upon the silencing o f E N 02, resultant

loss-of-function phenotypes may provide useful information on the functions o f this
enzyme. In this section, I will review some techniques used in loss-of-functions
phenotype analysis in T. gondii.

1.3.1 Gene targeting in T. gondii
Gene targeting, including gene knockout and knockin, has been widely used in
many organisms such as yeast, Arabidopsis, Drosophila and mouse for analysis o f gene
functions. Gene targeting is based on homologous recombination, which involves the
exchange o f DNA between sequences o f perfect or near perfect homology over several
hundreds o f base pairs. The process o f homologous recombination plays essential roles in
the mitotic and meiotic cell cycles o f most eukaryotic organisms. However, in most o f the
eukaryotes, the opportunity o f homologous recombination is extremely low when
compared with non-homologous recombination, rendering the efficiency o f gene
targeting to be low as well (Muller, 1999).
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Toxoplasma gondii, which has haploid genome during its asexual life cycle, is very
amendable for gene silencing and replacement. In gene targeting, constructs carrying the
desired mutated allele o f the interested gene with selectable markers are used in the
transformation o f parasites, and the homologous DNA fragment targets would guide and
direct the homologous recombination to occur at corresponding chromosome locus. Thus,
researchers can disrupt or delete the target gene or part o f it (so-called knockout, KO), or
replace the original gene with either a mutated one or another gene (so-called knockin, KI)
(Koller and Smithies, 1992; Hanin and Paszkowski, 2003; Rong, 2002). Up to now,
several

genes

of

T.

gondii,

including

HXGPRT,

UPRT,

dihydrofolate

reductase-thymidylate synthase (DHFR-TS) and BAG1 were reported to be knocked-out
or replaced (Donald and Roos, 1998; Bohne et al., 1998; Bohne et al., 1994; Donald and
Roos, 1994).
One o f the often-utilized methods to increase the efficiency o f gene targeting is
increasing the length o f homologous regions required for homologous recombination. At
the locus o f T. gondii DHFR-TS, when genomic fragments o f 8 kb homology were used
as a circular plasmid in the transformation, ~50% o f the transformed parasites harbored
transgenes integrated by homologous transformation. When a 16 kb genomic fragment
was utilized, >80% homologous recombination was observed (Donald and Roos, 1994).
Furthermore, advancements o f positive-negative selection system and efficient
molecular screening methods have made gene targeting more effective in many
organisms (Mansour et al., 1988). Additionally, the development o f conditional gene
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targeting including tissue- or cell-type specific gene targeting and temporal-inducible
gene targeting has rendered gene targeting a more flexible and promising tools for the
study o f various genes (Sauer, 1998; Utomo et ah, 1999).
It is possible to generate null mutants by gene knockout in T. gondii, which enables
the study o f gene function that can lead to the identification o f potential drug targets.
Although the frequency o f homologous recombination in T. gondii is relatively high, it is
not convenient to silence enolase isoforms by gene targeting becausetheir genomic loci
are almost overlapped. To create a knockout or a knockin of either E N O l or E N 0 2 would
interfere with the other. Moreover, it is highly likely that the null mutant would be lethal.
To circumvent these potential difficulties, RNA interference is used. The introduction of
dsRNA would attenuate the expression o f enolases and allow us to dissect their functions.

1.3.2 RNA interference
RNAi is one o f the most remarkable biological discoveries in the last 20 years. It is
an evolutionary conserved mechanism in which double-stranded RNA (dsRNA) or small
interference RNA (siRNA) initiates the specific silencing o f homologous genes. It is a
mechanism that is widely found in eukaryotes, including protozoa, insects and mammals
(Fire et al., 1998). It may function as a defensive mechanism to block the expression of
aberrant or harmful genes originating from viruses and transposons (Hannon, 2002).
RNAi also plays a fundamental role in genome rearrangement, chromosome remodeling
and stem cell maintenance (Sugiyama et al., 2005; Hatfield et al., 2005; Mochizuki and
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Gorovsky, 2005). Most importantly, RNAi is one o f the most powerful and convenient
tools to knock down specific gene expression and has a potential for gene therapy
(Novina and Sharp, 2004; Harper et al., 2005).

1.3.2.1 The discovery of RNA interference
The first observed phenomenon o f RNAi took place in 1990 in plant research when
scientists introduced a transgene designed to overexpress the enzyme chalcone synthase
in petunias aimed to deepen floral color. Unexpectedly these researchers found white
patchy flowers instead o f the expected increased flower pigmentation (Napoli et al., 1990;
van der Krol et al., 1990). They thought that it was the transgene that silenced the
expression o f the plant purple-flower genes. The phenomenon was named as
co-suppression, because the exogenous transgene suppressed the expression o f itself as
well as its endogenous homolog. The phenomenon remained obscure until similar gene
silencing effects (known as quelling) was observed in Caenorhabditis elegans upon
injection o f dsRNA (Fire et al., 1998). It was found that it was the dsRNA that lead to the
degradation o f target mRNA, known as post-transcriptional gene silencing (PTGS). Later
it was reported that RNAi was also functional in other organisms including fusion yeast
Schizosaccharomyces

pombe,

Drosophila

melanogaste,

Arabidopsis

thaliana,

Neurospora crassa as well as mammals (Hannon, 2002). Furthermore, it was also
reported that RNAi activity can persist through cell division rounds and growth, and that
RNAi is inheritable and transmissible (Fire et al., 1998).
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1.3.2.2 The mechanism of RNA interference
It is suggested that the suppressive effects o f RNAi can operate on several different
levels. The co-suppression effects in plants is triggered by DNA methylation o f the genes
which are homologous to dsRNA at cytosine residues, and thus these modified genes are
prevented from being transcribed (Wassenegger, 2005). However, the cleavage o f mRNA
homologous to dsRNA in post-transcriptional level is usually thought to be the most
essential pathway for the silencing effects o f dsRNA.
Genetic

and

biochemical

studies

have

contributed

tremendously

to

the

understanding o f the mechanism o f RNAi. Using extracts from Drosophila embryos and
tissue-cultured cells transfected with dsRNA, a nuclease capable o f degrading exogenous
homologous mRNA, was partially purified. This nuclease was co-purified with small
RNAs o f 21-25 nt long consisting o f sense and antisense sequences derived from within
the used regions (Tuschl et al., 1999; Elbashir et al., 2001; Yang et al., 2000). Incubation
o f a cell-free system from Drosophila embryos with both the dsRNA and its homologous
mRNA exhibited RNAi activity as found in vivo. And preincubation o f the cell-free lysate
with the dsRNA potentiated the degrading activity o f the lysate on the target mRNA in
vitro (Hammond et al., 2000; Zamore et al., 2000). These series o f experiments led to a
model o f RNAi pathways consisting o f initiation and effecter steps.
In the initiation step, an RNase III like enzyme known as Dicer recognizes and
digests dsRNA into small interference RNA (siRNA) in an ATP-dependent manner. Dicer,
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a highly conserved protein found in worms, flies, plants, fungi and mammals, basically
consists o f a dsRNA binding domain and one or two RNase III nuclease domains
(Elbashir et al., 2001). These 21-25 nt siRNA, RNA duplex carrying 5’-phosphate and
3 ’-hydroxyl termini with 2-nt overhanging 3 ' end, can later incorporates into a -3 6 0 kDa
ribonucleoprotein nuclease-complex called the RNA induced silencing complex (RISC)
(Hannon, 2002). The exact components o f RISC are not clear now, with the exception of
the Argonaute family protein that is supposed to be the essential element in the complex.
The Argonaute proteins are divided into two sub-families, known as Argonaute 1-like
(after the Arabidopsis Argonaute 1) and Piwi-like (after the Drosophila Piwi), depending
on the existence of N-terminal PAZ domain in addition to the highly conserved
C-terminal Piwi domain found in all Argonaute proteins (Liu et al., 2004). Argonaute
proteins were reported to be able to bind with Dicer, suggesting that their interaction is
important for the loading o f siRNA into RISC. In the effecter step, the siRNA is first
unwound in an ATP-dependent process. The formed single-stranded small RNA guides
the RISC to homologous mRNA and subsequently cleaves it at 10-11 nt away from the 3 ’
terminus o f the guide RNA. The 5 'phosphate group on the siRNA is essential for
assembly with the RISC and subsequent target cleavage (Elbashir et al., 2001; Hannon,
2002). Moreover, heterochromatin formation is also one possible pathway to inhibit
target gene expression (Wassenegger, 2005).
Furthermore, Dicer can digest hairpin RNA precursors into micro RNA (miRNA),
20-25 nt single-stranded RNA that is able to mediate translation repression. miRNA can
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incorporate into a protein complex known as miRNA-containing ribonucloprotein
(miRNP) complex, which also contains a Argonaute family protein. In some organisms
such as human, miRNP can guide miRNA to bind with homologous mRNA and inhibit its
translation without affecting mRNA levels (Nelson et al., 2004).
Other components o f RNAi machinery, including R2D2, a Dicer interacting protein
found to be important to load siRNA into RISC, were also reported. Among them, RNA
dependent RNA polymerase (RdRP), which was reported to be able to amplify RNAi
signals, is suggested to be essential for RNAi in some organisms, such as Neurospora
crassa, and Schizosaccharomyces pom be (Cogoni and Macino, 1999; Hall et al., 2002).
The siRNA can bind with the target transcript as primer, and RdRP can extend the
primers and generate the complementary RNA strand, resulting in a dsRNA which may
serve as a new substrate for Dicer (Martienssen, 2003). Moreover, in S. pombe, it was
also shown that RdRP was essential for RNAi-mediated heterochromatin assembly
(Sugiyama et al., 2005; Hall et al., 2002). However, RdRP may be not required for RNAi
in some other organisms. In Caenorhabditis elegans, it was reported that the mutant for
the gene ego-1 encoding its RdRP homologue showed similar RNAi activity when
compared to the wild type (Sijen et al., 2001). Drosophila and mammals, containing no
RdRP homologues in its genome, still exhibit gene-silencing efficiency at the
post-transcriptional level (Cottrell and Doering, 2003). It appears that RdRP is not a
universal component o f the RNAi pathway and that its function can be organism specific.
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However, it is also possible that these organisms have distinct or divergent RdRP
expression.
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Figure 1.4
The mechanism of RNA interference
Legend

The first commintting step o f the RNA interference pathway is catalyzed by Dicer
which digests endogenous and exogenous dsRNA and generates siRNAs. The siRNA is
loaded into RISC and directs the complex to silence gene by mRNA degradation,
translational inhibition, or chromatin remodeling. In some organisms, RdRP-dependent
synthesis o f new dsRNA may be used to amplify RNAi signals. The figure is adopted
from Hannon GJ, 2002
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Figure 1.4
The mechanism of RNA interference
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1.3.2.3 The application of RNA interference
RNAi is a powerful tool to suppress specific gene expression for reverse genetic
studies and to elucidate the functions o f genes in different organisms. The emergence o f
high throughput RNAi microarray chips has provided an important tool to analyze the
functions o f new genes coming from high throughput sequencing centers (Silva et al.,
2004). Moreover, RNAi technology is frequently employed in identify novel drug targets
and is a potential therapy for some diseases. Many pharmaceutical companies and
research centers have launched RNAi-therapy programs. Actually, any diseases could be
potential targets for RNAi-therapy. For example, in mice, siRNA homologous tumor
necrosis factor a (TNFa) was reported to be able to inhibit joint inflammation caused by
collagen induced arthritis (CIA) (Schiffelers et al., 2005). In addition, by using siRNA
expression vector to inhibit the expression o f HIV cellular receptor CD4 and coreceptors
CXCR4 and CCR5, HIV infection on T cells can be significantly reduced (Anderson and
Akkina, 2005). Specific siRNA is also reported to be able to inhibit growth o f cancer
cells (Takei et al., 2004; Leng and Mixson, 2005).
For the application of RNAi in research, many parameters need to be considered
including specificities and length o f the dsRNA utilized, types o f cells employed, as well
as the method o f dsRNA delivery. In tissue culture, methods such as electroporation,
microinjection, and lipid mediated gene delivery are often used to deliver dsRNA or
siRNA to cells (Parrish and Fire, 2001; Elbashir et al., 2001). For Caenorhabditis elegans,
feeding on dsRNA-expressing bacteria or even soaking in the solution o f dsRNA can
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successfully deliver dsRNA into cells (Timmons and Fire, 1998; Tabara et al., 1998).
Moreover, stable transformations, which can produce stable RNAi effects, with vectors
expressing dsRNA and siRNA, have been put into practice. The target sequence can be
inserted into a plasmid as inverted repeats so that the dsRNA is expressed as a hairpin
dsRNA in vivo (Sui et al., 2002; Paddison et al., 2002). A target sequence can also be
placed between two promoters arranged in a head-to-head fashion (Tschudi et al., 2003;
Al-Anouti et al., 2004; LaCount et al., 2000). In addition, inducible expression systems
such as tetracycline-inducible vectors, and stage- and tissue-specific expression systems,
were reported to be utilized in RNA silencing experiment and may have great prospect in
the future study (Cottrell and Doering, 2003; Anderson and Akkina, 2005).
However, there is some concerns about using dsRNA in mammalian systems due to
a protective antiviral response system which leads to a non-specific inhibition of host
gene expression (Huppi et al., 2005). But this difficulty can be avoided by using
embryonic cells instead o f non-embryonic cells, or by using siRNA instead o f long
dsRNA (Yang et al., 2002; Elbashir et al., 2001; Huppi et al., 2005).

1.3.2.4 RNAi in protozoa parasites
When RNAi was first put into practice for the down-regulation o f gene expression,
it was used in the protozoa Trypanosome brucei (Ngo et al., 1998). Genome searching
has shown that T. brucei contains members o f Argonaute family proteins but no Dicer
homologues (Shi et al., 2004; Ullu et al., 2004). For other members o f the

37

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Trypanosomatidae family, Trypanosoma congonlese was found to have RNAi functions,
while T. cruzi and Leishmania major, were revealed to be RNAi negative and their
genome databases show no homologues o f Dicer and Argonaute (Ullu et al., 2004). In
addition, RNAi was reported to be functional in T. gondii, as well as in Plasmodium
falciparum, another member o f Apicomplexa family (Malhotra et al., 2002; McRobert
and McConkey, 2002; Al-Anouti et al., 2003). The presence o f classical RNAi genes,
including potential homologues o f Argonaute, Dicer and RdRP, were reported from
database mining o f the T. gondii predicted coding regions. The presence o f Argonaute
family protein was reported in T. gondii, further supporting the functioning o f RNAi in
the parasites (Riyahi et al.,).
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Objectives
Stage-specific expression and nuclear localization o f enolase isoforms in
Toxoplasma gondii suggest additional important functions o f this glycolotic enzyme in
the parasites and provide potential drug targets for toxoplasmosis treatment. But limited
knowledge has been acquired about enolase up to now. The objective o f this study was to
investigate the possible role o f EN 02 in the development o f T. gondii, including their
involvement in parasite growth and stage differentiation. We would also like to
investigate the effectiveness and specificity o f dsRNA induced gene silencing in T.
gondii.
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CHAPTER 2
MATERIALS AND METHODS

2.1 Parasite Strains
Toxoplasma gondii strains RHAHX and RH were obtained from the AIDS
Research and Reference Reagent Program, NIH. RHAHX strain is generated from RH
strain and contains a deleted HXGPRT gene which allows for the slection o f transfected
parasites (Donald and Roos, 1998).

2.2 Materials and Chemicals
Chemicals and reagents that were used in this study are listed below.

Amersham-Pharmacia Biotech (Baie d’Urfe, Quebec).
C alf

intestinal

alkaline

phosphatase

(CIAP),

T7

RNA

polymerase,

2 ’-deoxyribonucleoside 5 ’-triphosphates (dNTPs), ribonucleoside triphosphates (rNTPs),
nitrocellulose membranes, and ECL western blot detection reagent.
Baxter Diagnostics Corp. (Toronto, ON)
Nalgene ™ disposable 25mm syringe filters (0.2pm pore size) and glass Pasteur pipettes
Bio-Rad Laboratories (Mississauga, ON)
Bromophenol Blue, Coomassie Brilliant Blue R-250, Xylene Cyanol, and Bio-Rad
protein assay dye reagents
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Gelman Sciences (Ann Arbor, MI)
The Vacucap ™ disposable bottle-top filter for sterilization o f cell media
GibcoBRL (Burlington, ON)
Cell culture media Dulbecco’s modified medium (DMEM), minimal essential medium
(MEM), dialyzed fetal bovine serum (dFBS), Dulbecco’s phosphate buffer supplemented
with calcium (DPBS), Trypan Blue (4%) Trypsin-EDTA (0.25% Tripsin, lm M EDTA)
and penicillin-streptomycin (10,000 u/ml)
Hyclone (Logan, UT)
10% cosmic calf serum
Invitrogen Corporation (Burlington, ON)
Proteinase K, Trizol, and RNase Out ribonuclease inhibitor, TOP 10 E.coli competent
cells and BL21 (DE3) competent cells
Molecular Probes (Eugene, OR)
Goat anti-rabbit IgG conjugated to rhodamine
New England BioLabs Inc.
Restriction enzymes Kpnl, Nsil, Ndel and Xbal
Omega Bio-tek (Doraville, GA)
EaZy Nucleic Acid Isolation Plasmid Midiprep Kit
Perkin Elmer (Norwalk, CT)
[3H] uracil and [3H] hypoxanthine monohydrogen chloride
Promega (Madison, WI)
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Agarose, DNA polymerase (Klenow) fragments, Moloney murine leukemia virus
(M-MLV) reverse transcriptase, RQ1 RNase-free DNase, Multicore buffer, C alf intestinal
alkaline phosphatase (CIAP), T4 DNA ligase and restriction enzymes S a d , Hindlll,
H in d i, BamHl, EcoRl, Pvull and Xhol
Qiagen (Mississauga, ON)
The Qiaex ® II Gel Extraction Kit
Roche Diagnostics (Laval, Qubec)
Taq DNA polymerase
Sarstedt Incorporation (Newton, NC, USA)
Conical 15 ml and 50 ml graduated polypropylene centrifuge tubes, disposable pipette
tips, 24 and 96 well plates, Petri dishes, cell scrapers, and T75 and T25 tissue culture
flasks
Sigma-Aldrich (Oakville, ON)
Acetic acid, ampicillin, chloroform, DNA ladders, 4 ,6 diamidino-2-phenylindole (DAPI),
Dolichos biflorus conjugated to fluorescein isothiocyanate (Cormack et al., 1996),
dimethylsulfoxide (DMSO), dithiothreitol (DTT), diethylpolycarbonate (DEPC), ethanol,
ethylenediaminetetra-acetic acid disodium salt (EDTA),
formaldehyde,

glycine,

morpholinopropanesulfonic

glycerol,
acid

ethidium bromide, formamide,

hydrochloric

(MOPS),

mycophenolic

acid,
acid

(MPA),

methanol,
pepsin,

polyoxyethylene sorbitan monolaurate (Tween-20), 2-propanol, phenylmethyl sulfonyl
fluoride (PMSF), pyruvate, scintillation fluid, sodium citrate, sodium chloride, sodium
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acetate,

N,N,N’,N’

tetramethyl

ethylenediamine

(TEMED),

tris-hydroymethylaminomethane (Tris), Triton X-100, Trichloroacetic acid, xanthine
TaKaRa Bio Inc.
Mung Bean Nuclease, T4 DNA ligase, restriction enzymes S a d i, H in d i, and BamHl
USB (Cleveland, OH)
Acrylamide, bis-acrylamide, ammonium persulfate (APS), equilibrated phenol, RNase A
and sodium dodecyl sulphate (SDS)
Wisent (Montreal)
Dialyzed fetal bovine serum (FBS)

2.3 Apparatus and instrumentation
Agarose gel electrophoresis o f DNA and RNA was carried out using the Miniature
Horizontal Gel System MLB-06 from Tyler Research Instruments. Alphalmager™ 2200
Light Imaging System with AlphaEase software was used to view gels and take images.
Sodium dodecyl sulfute Polyacrylamide gel electrophoresis (SDS-PAGE) was performed
using the vertical gel electrophoresis system, including all the glasses, Teflon combs and
spacers, from Bethesa Research Laboratories (BRL).
Centrifugations were carried out in J2-HS Centrifuge (Beckman), the desktop
Eppendorf Model 5415C microcentrifuge from Desaga (Sarstedt Gruppe, Germany), or
the Br4i centrifuge (Jouan, SA). DNA, RNA and protein concentrations were quantified
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using

Shimadzu

UV-Visible

Recording

Spectrophotometer

UV-160

(Agilent

Technologies, ON). The quartz cuvettes used were from Sigma.
PCR reactions were performed using the 20-well Techgene Thermal Cycler
(Techne, Cambridge, UK). Ligation reactions and reverse transcription (RT) reactions
were incubated in the 48-well Perkin Elmer Cetus DNA thermal Cycler (Perkin Elmer,
Norwalk, CT).
Parasite and cell culturing was performed under the Class II type A/B3 Biosafety
cabinet (Jouan, SA). All cultures were maintained in Thermo Forma CO 2 incubator
(Thermo Forma). Electroporations were conducted using the BTX model 600 Electro
Cell Manipulator (Genetronics). Bacterial cultures were grown in the New Brunswick
Scientific G-25R shaking incubator

2.4 Cell cultures
Cell and parasite culture was always conducted under sterile conditions in the Class
II type A/B3 Biosafety cabinet (Jouan, SA), and all cultures were maintained in a CO 2
incubator (Thermo Forma).

2.4.1 H um an foreskin fibroblasts (HFF) culture

Normal Human foreskin fibroblasts (HFF, obtained from Dr. D. Roos, University
of Pennsylvania) were used as the host for T. gondii. HFF cell monolayers were cultured
in DIO complete medium (composed o f Dulbecco’s Modified Eagle Medium (DMEM)
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supplemented with 10% cosmic calf serum, 5 ptg/jul streptomycin, 5 units/ml penicillin)
and grown in 5% CO 2 atmosphere at 37 °C.
Confluent HFF cell monolayers were subcultured using trypsin solution (0.25%
trypsin, 0.03% EDTA) followed by 1 minute incubation at 37 °C. Un-adhered cells were
resuspended in fresh DIO complete media and split into 4-5x area o f the old culture.
HHF were stored using a solution containing 12.5% dimethyl sulfoxideand 10%
dialyzed fetal bovine serum (FBS) in D10 medium. The cells were then aliqouted into
cryogenic vials and stored at -8 0 °C and later in liquid nitrogen for future use.

2.4.2 T. gondii culture
Toxoplasma gondii was propagated in HFF grown in EDI complete medium
(Modified Eagle Medium (MEM) containing 1% dialyzed FBS, 5 pg/pl streptomycin and
5 units/ml penicillin) at 37 °C in 5% CO 2 atmosphere. When the parasites completely
lysed the monolayers, the plate was scraped and newly released T. gondii was used to
infect another confluent HFF monolayer.
To store the parasites for future use, the parasites were re-suspended in solution
containing 12.5% DMSO and 10% dialyzed FBS in EDI medium. The cells were then
placed in freezing vials and stored at -8 0 °C and later in liquid nitrogen for future use.
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2.5 Construction of dsRNA expression plasmid
The DNA fragments encoding 1-542 bp nucleotides starting from start codon o f
E N O l and E N 02 open reading frames (ORFs) were amplified from pEN O l and pEN 02
expression plasmids acquired form Dr. S. Tomovo (Universite des Sciences et
Technologies de Lille, France) (Dzierszinski et a l, 2001), and oligonucleotide primers
called 5 ’-ENOx and 3 ’-ENOx. This set o f primers match perfectly with the EN O l gene
sequence. They also show high homology with the E N 0 2 gene sequence and are found to
be able to amplify 1-542 bp E N 0 2 ORF DNA fragment by PCR.
The plasmid producing dsRNA was designed to put the target sequence between
two promoters arranged as an inverted repeat that allowed transcription o f both strands o f
the DNA sequence located between them. Such construction was reported to be
functional in many organisms such as Trypanosoma congolense, Trypanosoma brucei as
well as T. gondii (Bannai H et al., 2003, LaCount et al., 2000, Al-Anouti et al., 2003).
542 bp DNA fragments o f EN O l and E N 0 2 were placed into the plasmid vector
p(TUB 8 )2 , between two TUB 8 promoters respectively. And to allow selection for the
positively transformed parasites with medium containing mycophenolic acid (MPA) and
xanthine,

an

expression

cassette

of

hypoxanthine-xanthine-guanine

phosphoribosyltransferase (HXGPRT) was also cloned into the constructed plasmids,
producing plasmids named as p(TUBS)2EN01 -HX, and p(TUB8)2EN02-HX respectively.
An ampicillin resistant gene also existed in the plasmids for bacterial selection under
antibiotic pressure. To serve as a negative control, a 533 bp DNA fragments o f green
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fluorescence

protein

(Cormack

et

al.,

1996)

gene

amplified

from

plasmid

pTub 8 mycHisGF.P-.ffif by PCR using T7-5GFPmut2 and T7-3GFPmut2 primers was
also cloned into the vector to generate the plasmid p(TUB 8 ) 2 GFP-HX. The Scheme o f the
plasmids constructed is shown in Fig. 3.2. Appendix III.
The coding sequences o f E N O l and E N 0 2 and rhoptry protein 1 (Soldati et al.,
1995) as well as Argonaut (AGO) were obtained from the T. gondii sequence database
(http://www.toxodb.org) (Kissinger et al., 2003) and were used to design oligonucleotide
primers (T7on5’F O P T7on3’FO P 5’ENOx, VENOx, TlonS'E N O x and TlonV E N O x, all
sequences are listed in Appendix II) for PCR reaction.

2.5.1 RNA extraction from T. gondii
Freshly released T. gondii were passed through a 27G1/2 syringe needle, filtered
through a 3 pm polycarbonate filter to remove host cell debris and harvested by
centrifugation at 3,000x g for 10 minutes. The parasites were lysed using TRIZOL®
Reagent and RNA was extracted as per the manufacturer’s instruction. The obtained RNA
samples were dissolved in 20 pi o f DEPC H 2 O.
To remove genomic DNA contamination, the RNA samples were treated with 4
units RQ1 RNase-free DNase (Promega) for 30 minutes at 37 °C. The DNase was
inactivated by heating at 75 °C for 5 minutes, followed by phenol/chloroform treatment.
The RNA samples were recovered from the aqueous phase by precipitating using 2.2
volumes o f 100% ethanol and 0.1 volume o f 3 M sodium acetate (pH 5.2) and were
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centrifuged at 12000x g for 15 minutes. After washing with 70% ethanol, the RNA pellet
was dissolved in 20 pi o f DEPC H 2 O.

2.5.1.1 Agarose gel electrophoresis
The total RNAs extracted from T. gondii were visualized on 1% agarose gel, and
the presence o f 18s and 28s ribosomal RNA was used as the internal control. To visualize
the DNA or RNA in the gel, ethidium bromide was added to the agarose solution to a
final concentration o f 10 ng/ml. The gel was allowed to solidify in the electrophoresis
tray and was placed in the electrophoresis tank filled with lx TAE buffer. DNA/RNA
samples were mixed with gel loading buffer (6x: 0.25% (w/v) bromophenol blue, 0.25%
(w/v) xylene cyanol FF, and 40% (w/v) sucrose in water) and were loaded into the well
along. The gel was run in lx TAE buffer for 0.5 to 1 hour at -1 0 0 v. The gel was then
visualized and photographed in Alphaimager 2200 Light Imaging System with AlphaEase
software.

2.5.2 Reverse transcription and polymerase chain reaction (RT-PCR)
Complementary DNA (cDNA) was generated using a reverse transcription reaction
and oligodT-primer (Appendix II). The cDNA products were used as templates for PCR.
The concentration o f RNA was determined by measuring the absorbance at 260 nm
([RNA] = A 260 nmX dilution factor x (40 pg/ml)). In order to determine the purity o f DNA
from proteins, the absorbance was also measured at 280 nm and compared to that at 260
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nm .

2.5.2.1 Reverse transcription (RT)
The reverse transcription reactions were carried out using 2 pg o f total RNA after
DNase treatment as initial templates. The RNA samples were subjected to PCR to
confirm no DNA contamination. 5 pmoles o f oligodT primer was add to the RNA
samples, followed by incubation at 65 °C for 5 minutes to remove secondary structures o f
RNA, and cooling on ice for 1 minute. After centrifuging briefly, the mixture was finally
completed in a total volume of 10 pi containing 50 mM Tris-HCl (pH 8.3), 75 mM KC1,
10 mM DTT, 3 mM M gCb, 1 mM each dNTP, 20 u (0.5 pL) RNase-out RNase inhibitor
and 100 u (0.5 pi) Moloney murine leukemia vims (M-MLV) reverse transcriptase
(Promega). The reactions were incubated at 42 °C for 90 minutes, followed by heating at
70 °C for 15 minutes to inactivate the reverse transcriptase.

2.5.2.2 Polymerase chain reaction (PCR)
Polymerase chain reactions were performed using the 20-well Techgene thermal
cycler (Techne, Cambridge, UK). All the oligonucleotide primers used in the study were
synthesized by Integrated DNA Technologies (Coralville, IA). The sequences o f all the
oligonucleotide primers used in the study are listed in Appendix II. 2 pi o f RT reaction
mixture was used for the subsequent PCR amplification. The PCR was performed in a
total volume o f 25 pL containing 75 mM Tris-HCl pH

8 .8

, 50 mM KC1, 2.5 mM MgCb,
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100 pM dNTPs, 50 pmoles o f each oligonucleotide primer (5’ENOx and 3 ’ENOx), and
0.5 pL o f Taq DNA polymerase. The reaction condition for E N O land E N 02 gene
fragments amplification was 94 °C 5 min + 35 x (94 °C 30s, 42 °C 30s, 37 °C 75s) + 72
°C 5 min. The PCR products were visualized on 1% agarose gel.

2.5.3 Preparation of vector
The DNA plasmid p(TUB 8 ) 2 -CAT was digested with Nsil and treated by Mung
Bean Nuclease to produce blunt ends for the cloning o f the

DNA fragments encoding

E N O l or E N 02. The sequences and digestion analyses o f these constructs are shown in
Appendix III.

2.5.3.1 Plasmid miniprep
An isolated bacterial colony was used to inoculate 2 ml o f LB broth supplemented
with ampicillin (100 pg/ml). The culture was incubated at 37 °C overnight at 250 rpm.
Following incubation, 1.5 ml o f the culture was transferred to a 1.5-ml microtube and
was centrifuged at 12,000x g for 1 minute to collect the cells. After removing the medium
and drying briefly, the pelleted cells were resuspended in

100

pi o f a ice-cold solution

containing 50 mM glucose, 25 mM Tris-HCl (pH 8.0), and lOmM EDTA. Then the
suspended cells were lysed by the addition o f 200 pi o f solution containing 0.2 N NaOH,
1% SDS prior to incubation on ice. Following a 2 to 3 minutes incubation, 150 pi of
ice-cold 3 M NaOAc, pH 5.2 was added to precipitate chromosomal DNA and
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SDS-protein complex. After incubation on ice for 5 minutes, the mixture was centrifuged
at 12,000x g for 5 minutes.

The clear supernatant (-450 pi) was then transferred to

another 1.5-ml tube and 450 pi o f TE-buffered phenol:chloroform:isoamyl alcohol
(25:24:1) was added. This mixture was vortexed for 30 seconds and then centrifuged at
12,000x g for 1 minute at room temperature. The top aqueous phase was then transferred
to a fresh tube and 900 pi o f 95% ethanol was added to precipitate the plasmid. This
mixture was then vortexed for approximately 30 seconds and left standing at room
temperature for 2 minutes, followed by centrifugation at 12,00x g for 10 minutes at 4°C.
The resulting DNA pellet was washed with 450 pi o f 70% ethanol and the mixture was
centrifuged at 7,500x g for approximately 3 minutes. The final pellet was resuspended in
30pl o f lx TE buffer containing 20 pg/ml RNase, and incubated at 37 °C for 15 to 20
minutes to remove RNA.

2.5.3.2 Restriction enzyme digestion
Restriction enzyme digestion was used in the analysis and preparation o f plasmids
as well as DNA fragments for cloning. The reaction mixture was made by adding 1 pi
lOx enzyme reaction buffer provided with the enzyme and 0.5 pi o f desired enzyme to an
adequate amount o f DNA solution (<1 pg), followed by adding o f ddfEO to make the
reactionlO pi. The mixture was incubated at 37 °C for 4 to 16 hours, followed by
visualization using agarose gel. The treated DNA can be purified by phenol: chloroform
treatment and precipitated with ethanol.
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2.5.3.3 Mung Bean Nuclease treatment
Mung Bean Nuclease reactions were carried out to create blunt ends for the ligation
of incompatible sticky ends. The general reaction involved the use o f 25pl o f DNA (<1
pg), 3 pi o f lOx buffer (0.03 M sodium acetate (pH 5.0), 0.05 M NaCl, 1 mM ZnC^), 0.5
pi (45 u/pl) o f Mung Bean Nuclease (TaKaRa), and 1.5 pi o f H 2 O. After the addition of
Mung Bean Nuclease, the samples were incubated at 37 °C for 15 minutes to let the
enzyme work. The treated DNA sample was either purified by phenol: chloroform
treatment followed by ethanol precipitation, or subjected to gel purification directly.

2.5.3.4 Calf Intestinal Alkaline phosphatase (CIAP) treatment
In the process o f inserting HXG PRT cassette into constructed plasmids, CIAP was
used to remove the phosphate group o f the vectors to prevent the self-ligation in the
ligation reaction. Briefly, the reaction was made o f 20 pi o f DNA (<1 pg), 3 pi o f lOx
CIAP buffer, 0.5 pi (1 u/pl) o f CIAP (Promega), and 6.5 pi o f H 2 O. The reaction mixture
was incubated at 37 °C for 30 minutes, followed by adding another 0.5 pi CIAP and
another 30 minutes 37 °C incubation. The treated DNA sample was either purified by
phenol: chloroform treatment followed by ethanol precipitation, or subjected to gel
purification directly.

52

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

2.5.4 Gel purification of DNA fragm ents
To obtain purified DNA fragments for ligation, the DNA samples were resolved on
1% agarose gel by electrophoresis, the E N O l and E N 02 DNA fragments as well as
plasmid vector were excised and purified using Q IA EX II Gel Extraction Kit as described
by the manufacturer (Qiagen catalog No. 20021). Finally, extracted DNA sample was
dissolved in 30 pi of ddH 2 0 , visualized in 1% agarose gel and frozen at -2 0 °C for future
use.

2.5.5 Ligation
After purification o f the DNA fragments o f E N O l and E N 02, they were ligated
with gel-purified p(TUB 8 ) 2 plasmid vector. 4 pi o f insert was mixed with

1

pi o f vector, 1

pi 10 x Ligase Buffer (300 mM Tris-HCl (pH 7.8) 100 mM MgCl2, 100 mM DTT and 10
mM ATP), 0.5 pi o f T4 DNA Ligase (3 u/pl) (Promega), and 3.5 pi o f ddH 2 0 . The
reaction was incubated overnight at 16 °C. H alf o f this reaction mixture was then used for
transformation into subcloning-grade competent cells.

2.5.6 Transformation of E. coli with plasmids
To maintain sterile conditions throughout bacterial culturing procedures, all broth
solutions and glassware were autoclaved prior to use.
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2.5.6.1 Preparation of competent bacteria
XL 1-Blue M RF’ Escherichia coli (Stratagene) was grown on an LB agar plate
containing tetracycline (100 pg/ml). A single colony was inoculated from the plate into 3
ml LB broth with tetracycline and grown overnight in the shaker incubator at 37 °C at
250 rpm. The second day, 1 ml o f the culture was used to inoculate a 100 ml LB broth
without antibiotics. The bacteria were shaken at 37 °C for 3 hours to let OD 595 nm reaches
04-0.6. Then, the bacteria were chilled on ice for 30 minutes and then pelleted at 4000x g
for 15 minutes at 4 °C in 50 ml Falcon tubes. 45 ml o f the supernatant was discarded and
the remaining 10 ml was used to resuspend the bacteria pellet. 30 ml cold sterile 100 mM
CaCL solution was then added to wash the cell pellet. The suspended pellet was
centrifuged again at 4000x g for 15 minutes. The supernatant was removed and the pellet
was further washed with 40 ml 100 mM C aC^ solution for two times followed by
centrifugation. The pelleted bacteria were finally resuspended in a 2ml solution
containing 100 mM CaCL and 25% glycerol, aliquoted into 600 pi microfuge tubes and
finally stored at -80°C for at least overnight before use (Sambrook et al, 1989).

2.5.6.2 Transformation of competent bacteria with plasmids
H alf o f the ligation reaction product was added to 25 pi o f freshly thawed
competent E. coli. After 20 minutes o f incubation on ice, the cell suspension was heat
shocked at 42 °C for 45 seconds and further incubated on ice for another 2 minutes. After
the addition o f 400 pi LB broth, the bacteria were incubated at 37 °C for 30 to 45 minutes
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with shaking at 250 rpm. Approximately lOOpl o f this culture was spread on LB agar
plate containing 100 pg/ml ampicillin. Plates were then incubated overnight at 37 °C
(Sambrook et al, 1989).

2.5.7 Screening for the correctly constructed plasmids
Isolated colonies o f ampicillin resistant bacteria were screened for positive cloning
by PCR. Literally, single colonies were picked and grown in 100 pi LB broth
supplemented with 100 pg/ml ampicillin at 37 °C overnight. 50 pi o f the culture was
centrifuged at 12,000x g for 1 minute. The supernatant was removed and the pelleted
cells were resuspended in 20 pi o f TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH8.0).
The suspension was boiled for 10 minutes and spun down at 12,000x g for 1 minute. Up
to 2.5 pi o f the supernatant was used as the template for 25 pi PCR using primers
flanking the insert DNA fragments. PCR products were then visualized in 1% agarose
gel.
The potentially positive clones were further isolated by miniprep and subjected to
restriction enzyme digestion analysis to search for the correctly constructed plasmids.

2.5.8 Insertion o f HXGPRT cassette into plasmid
The H XG P RT cassette was also cloned into the plasmids to serve as a positive
selectable marker used to select positively transformed parasites from the untransformed
ones. Briefly, the HXGPRT cassette DNA fragment was digested from the plasmid
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pTub 8 mycHisGFP-HX by restriction enzyme SaclI. The target plasmid was also
subjected to S a d i digestion followed by CIAP treatment. The digested HXG PRT cassette
insert and vector were purified by QIAEX II Gel Extraction Kit and used in ligation
reaction as described above. The ligation products were also used to transform XL 1-Blue
M RF’ E. coli competent cells, and were subjected to screening to get the expected
constructs. The sequences and digestion analyses o f these constructs are shown in
Appendix III.

2.6 T ransient dsRNA electroporation
To study whether dsRNA induced RNAi was available to knockdown the
expression o f enolase in T. gondii, synthesized dsRNAs homologous to two isoforms o f
enolase were transformed into the parasites by electroporation. And the consequences of
the dsRNA electroporation were studied by RT-PCR and western blot.

2.6.1 dsRNA synthesis by in vitro tran scrip tio n
DNA templates o f the transcription were synthesized by PCR using ENOx primers
set which had 17 nucleotides T7 promoters at 5 ’-end o f both oligonucleotides
(T7on5’ENOx and T7on3’ENOx, sequences are listed in Appendix II). And —550 bp
E N O l and E N O l DNA fragments were used as template for the PCR reaction. The PCR
product was purified using phenol/chloroform purification followed by ethanol
precipitation, and dissolved in DEPC treated water. 0.2 pg o f the PCR product was used
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in the in vitro transcription reaction as the template. The transcription reaction was
carried out in a total volume o f 100 pi containing 40 mM Tris-HCl (pH 8.0),

6

mM

MgCl2 , 10 mM NaCl, 10 mM DTT, 1/100 dilution pyrophosphate, 50 u RNaseOUT
RNAase inhibitor, 2.5 mM rNTP and 200 u T7 RNA polymerase. Transcription was
allowed to proceed at 37°C for 2.5 hours. At the end o f the incubation period, 2 units of
RNase free RQ1 DNase were add to the reaction, following by further incubated for 30
minutes to degrade DNA template. The product was finally purified by phenol:
chloroform extraction and the integrity o f the RNA sample was be confirmed by
resolving the sample on 1% agarose gel stained with ethidium bromide (Sambrook, 1989).
The concentration o f synthesized RNA was determined by spectrometry as described
above. Additionally, dsRNA homologous to GFP DNA was also produced with the same
approach.

2.6.2 Electroporation of dsRNA into T. gondii
After T. gondii tachyzoites o f strain RH had completely lysed a confluent HFF
monolayers plate, the parsites were scraped from culture plate, syringed through a
27G1/2 needle twice, filtered through a 3 pm membrane to remove host cellular debris.
The parasites were then harvested by centrifugation at 2000x g for 10 minutes at 4 °C
followed

by

washing

twice

with

Dulbecco’s

phosphate-buffered

saline

buffer

' yi

supplemented with 100 pg/ml Ca

(DPBS). The parasites were finally centrifuged at

2000x g for 10 minutes at 4 °C to collect the pellets, then resuspended in 800 pi
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electroporation buffer which contained 120 mM KC1, 0.15 mM CaCh, 10 mM
K 2 HPO 4 /KH 2 PO 4 (pH 7.6), 25 mM HEPES (pH 7.6), 2 mM EDTA and 5 mM MgCl2, and
was freshly supplemented with 2 mM ATP and 5 mM glutathione (GST). 10 pg dsRNA
was added to the resuspended T. gondii, and the mixture was transferred to the 4 mm
electroporation cuvettes (Ultident, St. Laurent, Quebec) and subjected to electroporation
using BTX model 600 Electro Cell Manipulator (Genetronics) with current o f 25 £2, 25
pF and 1.8 kEV. The electroporated parasites were then left standing in the
electroporation vial at room temperature for 15-30 minutes to restore their viabilities and
were then used to infect a new confluent HFF monolayers in EDI medium in 60mm
culture plate (Donald and Roos, 1994).

2.6.3 RT-PCR to study mRNA expression level
The total RNA o f T. gondii after dsRNA electroporation was extracted as described
above. The RNA samples were subjected to DNase treatment and subsequent PCR to
confirm no DNA contamination. 2 pg o f the total RNA was used in the RT reaction using
oligodT, which is complementary to the polyA tails o f mRNA, as the primer. 2 pi o f the
RT product is used in the PCR as the templates. The reaction condition for ROP1
amplification was 94 °C 5 min + 35 x (94 °C 30s, 55 °C 30s, 37 °C 45s) + 72°C 5 min.
The reaction condition for E N 0 2 amplification was 94 °C 5 min + 35 x (94 °C 30s, 42 °C
30s, 37 °C 75s) + 72 °C 5 min. The PCR products were subjected to agarose gel
electrophoresis to visualize the results. To make the amount o f ROP1 products to be equal,
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5.0pL o f d&ENOl RNA RT-PCR product, 3.5pL o f dsE N 0 2 RNA RT-PCR product and
6.0pL o f dsGFP RNA RT product from both E N 0 2 and ROP1 were loaded on the gel.

2.6.4 Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE)
and western blot
2.6.4.1 Protein quantification by Bradford assay
Freshly released T. gondii were passed through a 27G1/2 syringe needle, filtered
through a 3 pm polycarbonate filter to remove host cell debris and harvested by
centrifugation at 3,000x g for 10 minutes. The pelleted parasites were lysed with the
protein lysis buffer containing 50 mM HEPES (pH 7.4), 0.025% Triton X-100, 20%
glycerol, 10 mM PMSF, and centrifuged at 12,000x g for 10 minutes at 4 °C. The
concentrations o f cell lysates were determined by Bradford assay using the Agilent
UV-visible spectrophotometer as described on the manual. 10 pi o f the protein sample
was diluted with 1.59ml o f ddH 2 0 and mixed with 0.4 ml o f Bradford reagent (Bio-Rad).
After incubation at room temperature for 10 minutes, spectrophotometeric measurements
were carried out at 595 nm using the diluted Bradford Reagent as a blank. A standard
curve made with standard protein solutions o f BSA was used to determine the unknown
concentration o f protein in the sample (Sambrook et al, 1989).

2.6.4.2 SDS-PAGE
Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE) was
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conducted with a discontinuous buffer system (Laemmli, 1970). The stacking and
resolving gels were cast using the vertical gel electrophoresis system from BRL
(Bethesda Research Laboratories). The resolving gel solution (2.58 ml ddfLO, 1.8 ml
30% Acrylamide solution, 1.5 ml 1.0 M Tris-HCl pH

8 .8

, 60 pi 10%SDS, 60 pi 10%

ammonium persulfate, 5 pi TEMED to make total volume to be ~ 6 ml) was poured first
and left to polymerize before being overlaid by the stacking gel solution (1.46 ml d d ^ O ,
0.25 ml 30% Acrylamide solution, 0.25 ml 1.0M Tris-HCl pH 6 .8 , 20 pi 10% SDS, 20 pi
10% ammonium persulfate, 3 pi TEMED to make total volume to be ~2 ml).
The protein samples were mixed with gel loading buffer containing 6.25 mM
Tris-HCl (pH

6 .8

), 2% SDS, 10% glucose, 0.05% Bromophenol blue and 720 mM

2-mercaptoethanol, boiled for 5 minutes and loaded onto SDS-PAGE gel. The gel was
run in the Tris-glycine running buffer containing 196 mM glycine, 25 mM Tris-HCl (pH
8.4), 0.1% SDS, at 125 volts until the bromophenol blue dye reached the end o f the gel
(~90min).

2.6.4.3 Protein transfer and immuno-detection
The separated proteins on SDS-PAGE gel were subsequently transferred to
nitrocellulose membrane by electro-blotting in transfer buffer containing 192 mM glycine,
25 mM Tris-HCl (pH 7.4), 20% methanol at 80 volts for 1 to 2 hours. The efficiency of
transfer was determined by ponceau staining.
The blot was blocked in 5% skim milk in TBS (137 mM NaCl, 20 mM Tris-HCl,
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pH 7.6) for 1 hour at room temp and then incubated in 2% skim milk containing the
rabbit anti-EN02 antibody overnight at 4°C. After washing with TBST (0.2% Tween in
TBS) for 3x 10 minutes, the blot was incubated in 2% skim milk containing the goat
secondary antibody against rabbit IgG linked with horseraddish peroxidase for 1 to 2
hours at room temperature. After another wash with TBST for 3x 10 minutes, the blot is
visualized for EN 02 signals with Detection Reagent (Amersham Bioscience, Baie d’Urfe,
Quebec). Afterward, the blot was stripped with stripping solution containing 250 mM
glycine-HCl (pH 2.0), 1% SDS, treated with LDH1 primary antiboady, and finally
anti-rabbit secondary antibody to visualize LDH1 signals.

2.7 Generation of transgenic parasite lines
The constructed plasmids were used to generate transgenic parasite lines. The
plasmids were first extracted using E.Z.N.A Plasmid Midiprep Kit (Omega Bio-tek, GA),
and then were used to transform T. gondii strain RHAHX. The transformed parasites were
cultured under selective pressure to produce stable transgenic parasite lines.

2.7.1 Plasmid extraction by midiprep
The constructed plasmid was extracted from E. coli using E.Z.N.A Plasmid
Midiprep Kit from Omega Bio-tek according to manufacturer’s instruction. Literally, an
isolated colony was used to inoculate 100 ml o f LB broth supplemented with 100 pg/ml
ampicillin. The culture was incubated overnight at 37 °C in shaking incubator at 250 rpm.
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Then, 50 ml o f the overnight-cultured medium was placed in a 50 ml Falcon tube and the
cells were harvested by centrifuging at 4,000x g for 10 minutes. The cells were then
resuspended in 2.25 ml o f Solution I with RNase A. Then, the bacteria were lysed by
adding 2.25 ml o f Solution II, followed by gentle inversion for 7 to 10 times for through
mixing prior to incubation at room temperature for 5 minutes. The resulting mixture was
then neutralized with 3.2 ml o f Solution III and mixed by inversion for several times until
a flocculent white precipitate formed. The mixture was centrifuged at 12000x g for 10
minutes at room temperature to pellet the cellular debris and genomic DNA. Then, the
clear supernatant was transferred to a clean Hibind DNA Midi column assembled in a
15ml collect tube. The binding column was then centrifuged at 5,000x g for 5 minutes to
completely pass the lysate through the column (need two times to transfer all the DNA
solution to the column). Then 3 ml o f the Binding HB buffer was added to the top o f the
column followed by centrifugation at 5,000x g for 5 minutes. After washing the column
with 3.5ml DNA Wash Buffer diluted with ethonal and centrifuging at 5,000x g for 5
minutes, the resulting binding column was washed with 3 ml o f 100% ethonal and
centrifuged at 5,000x g for 3 minutes. Then, the column is subjected to centrifugation at
5,000x g for 10 minutes again to remove residue ethanol. Finally, 0.75 ml sterile
deionized water was added to the column. The column was transferred to a new clean
tube and subjected to centrifugation at 5,000x g for 5 minutes to elute out the DNA bind
with the column. The elution process was repeated to increase the yield o f plasmid DNA.
The DNA sample was visualized on 1% agarose gel containing ethidium bromide. The

62

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

concentration o f the plasmid solution was determined by measuring the absorbance o f the
DNA sample at 260 nm ([DNA] = A 260 nm x dilution factor x (50 pg/ml)). In order to
determine the purity o f DNA from proteins, the absorbance was also measured at 280 nm
and compared to that at 260nm.

2.7.2 T. gondii transform ation using electroporation and selection
To produce the stable ENOl and EN 02 knowckdown strains, lOpg o f the
plasmid p(TUB 8)2.E7VC>/-HX, p(TUB 8 ) 2E N 02-H X as well as the control plasmid
p(TUB 8 ) 2 G FP-//A w ere used to transform the parasites strain R H A ffifby electroporation
respectively. The operation of electropration was performed as described above. After
electroporation, the parasites were used to infect confluent HFF monolayers and
incubated in EDI complete medium for 24h at 37 °C in 5% CO 2 atmosphere. Then
selection was applied by culturing the parasites in EDI medium complemented with 25
pg/ml MPA and 50 pg/ml xanthine. Untransformed parasites were killed and the
transformed ones survived due to the expression o f exogenous HXGPRT. The selection
pressure was kept to maintain the expression o f the transgenes.

2.8 Characterization of transgenic parasite lines
To characterize the generated parasite lines, their genomic DNAs were extracted
and used as the template for PCR to check the existence o f the transgenes. Then, the
production o f dsRNA in these parasite lines was studied using RT-PCR. The expression
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level o f enolase was also monitored in the level o f RNA and protein, by RT-PCR and
western blot respectively.

2.8.1 Genomic DNA extraction and PCR
When T. gondii tachyzoites had completely lysed a confluent HFF monolayers,
they were scraped from culture plates, syringed through a 27G1/2 needle twice, filtered
through a 3 pm membrane to remove host cell debris. The cells are sedimented by
centrifugation at 3,000x g for 10 minutes at room temperature. The collected pellet was
washed twice with DPBS and was used for genomic DNA or total RNA extraction. To
extract genomic DNA o f T. gondii, the parasites pellet was resuspended in 250 pi
genomic DNA lysis buffer containinglOO mM EDTA, 10 mM Tris-HCl (pH 8.0) and 1%
SDS and 2 mg/ml Proteinase K. The mixture was incubated at 55-60 °C for 4 to

6

hours

to completely lyse the parasites. The suspension was then extracted three times with an
equal volume o f phenol xhloroform and twice with an equal volume o f chloroform. Then,
the genomic DNA was obtained from the aqueous phase by precipitating with two
volumes 95% ethanol and 1/10 volume 3M sodium acetate (pH 5.2). After 15 minutes
centrifugation at 5000x g at 4 °C, the DNA pellet was washed by 250 pi 70% ethonal and
dissolved in 30 pi ddHaO. The genomic DNA sample was resolved on 1% agarose gel, to
visualize the existence o f high molecular weight DNA band.
0.2 pg genomic DNA was used as the template for PCR. The 25 pi mixture o f PCR
is prepared as described above. The reaction condition for ROP1 and GFP amplification
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was 94 °C 5 min + 35 x (94 °C 30s, 55 °C 30s, 37 °C 45s) + 72°C 5 min. The reaction
condition for EN O l and E N 02 amplification was 94 °C 5min + 35 x (94 °C 30s, 42 °C
30s, 37 °C 75s) + 72°C 5min. The PCR products were visualized on 1% agarose gel.

2.8.2 Detection of dsRNA expression by RT-PCR
The total RNAs of different strains o f T. gondii were extracted as described above.
The RNA samples were subjected to DNase treatment and subsequent PCR to confirm no
DNA contamination. 2 pg o f the total RNA sample was used in the RT reaction using the
upper primers o f ENO primer set (5’ENOx) to produce the cDNA complementary to the
ENO antisense RNA, and primer 5 ,GFP was utilized to produce cDNA complementary
to GFP antisense RNA. The RT reaction was conducted as described above and 2 pi o f
the RT products was used as the template for PCR to detect the production o f dsRNA.

To study the expression level o f enolase in the levels o f mRNA and protein o f the
different parasite lines, RT-PCR and western blot were utilized and the operations are
performed as described in section 2.6.3 and 2.6.4 for transient enolase knockdown
experiments.

2.9 Immunofluorescence Assay
Newly released parasites were inoculated onto confluent HFF monolayers grown
on glass slides. For different stages o f the parasites, tachyzoites were then allowed to
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grow for 2-3 days, while intracellular bradyzoites were cultured for 4 days before
analysis. After removing culture media and washed with DPBS for 3 times, the cells were
fixed with 3% paraformaldehyde in phosphate buffered saline (PBS) for 10 minutes and
then permeabilized with 0.2% Triton X-100 in PBS for 15 minutes. Cells were then
blocked with 5% bovine serum albumin (BSA) in PBS for 1 hour at room temperature
(Yahiaoui et al., 1999). Slides were incubated for 1 hour with the primary antibody in a
humidity chamber. After three washes with PBS for 3 x 10 minutes, cells were incubated
for another 1 hour with seconday antibody conjugated to rhodamine or Fluorescein
isothiocyanate (Cormack et al., 1996) in a dark humidity chamber. Afterward, the slides
were washed with PBS for another three times. The nuclei o f the cells were stained by
incubation in the presence o f 4 ' , 6 diamidino-2-phenylindole (DAPI, Sigma) for 10
minutes, and three washings with PBS (Yahiaoui et al., 1999). For cyst staining, the cells
were stained with lectin from Dolichos biflorus conjugated to FITC (diluted 1:300, Sigma)
for 1 hour. The slides were dried in the air and overlaid with fluoromount, followed by
incubation at room temperature overnight in the dark. The cells were examined with a
Leica DMIRB microscope. All images were taken with a cooled Q-Imaging CCD camera
using the Improvision Openlab software.

2.10 Measurement o f parasite growth
The growth ability o f different parasite lines was analyzed by their amplification
ability. Freshly released tachyzoites were used to infect confluent HFF monolayer cells in
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EDI complete medium grown on glass slides. After growing for 24h and 48h, the slides
were washed with DPBS three times and were fixed with 3% paraformaldehyde in PBS
for 10 minutes. After permeabilization with with 0.2% Triton X-100 in PBS for 15
minutes, the fixed cells and parasites were incubated in DAPI solution for ten minutes to
stain their nuclei. After drying in the air, the slides were overlaid with fluoromount, and
incubated at room temperature overnight in the dark. The cells were examined with a
Leica DMIRB microscope. The numbers o f vacuoles containing different numbers of
parasites were counted and their ratios in total vacuoles were scored, and plotted.
The growth rates o f the transgenic parasite lines as well as the parental strain were
also measured by plaque assay. Briefly, newly released parasites o f different strains were
counted after staining with 0.4% Trypan Blue, and 5,000 live parasites were used to
infect confluent HFF monolayers in 35mm culture plates. After 24h incubation at 37 °C in
5% CO 2 atmosphere, the plates were sealed and incubated undisturbed for at least

6

days,

shielded from excess vibration. When plaques o f adequate size for visualization were
formed (usually ~9 days after infection), the cells were rinsed with PBS, fixed in
methanol, stained in crystal violet (to make 5 X stock, 25 g o f crystal violet was dissolved
in 250 ml ethanol and added to 1,000 ml 1% ammonium oxalate) and air-dried. Parasites
plaques appeared as irregular clear areas against mottled violet background produced by
stained confluent HFF cells. The numbers o f plaques were counted under optical
microscope.
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2.11 In vitro differentiation of I gondii
To differentiate the parasites from tachyzoites into bradyzoites, the alkaline method
was used. Briefly, freshly released tachyzoites were used to inoculate confluent HFF cells
in EDI complete medium and were allowed to invade the host cells for 4 hours. The
medium was subsequently replaced with RPMI1640 medium pH 8.2, containing 25 mM
HEPES, 5% fetal bovine serum, 5 jug/jal streptomycin, and 5 units/ml penicillin, and
incubated in a humid air atmosphere at 37 °C with 5% CO 2 . The medium was replaced
every one or two days to maintain the pH. And parasites were harvested immediately
after they had been released from HFF monolayers.
After 4 -6 days of bradyzoite differentiation using the alkaline method, the cells
were scraped and digested with 170 mM NaCl-pepsin (0.1 mg/ml) to free the bradyzoites
from the cells. After incubation in 60 mM HC1 for 1 minute at 37 °C, the cells suspension
was neutralized with 94 mM Na 2 C 0 3 . Collected parasites were passed through a 27G1/2
needle twice and filtered through a 3 pm filter (Nucleopore) to remove host cell debris.
Filter-purified parasites were then collected by centrifugation at 3,000x g for 10 minutes
and washed twice with DPBS. The collected bradyzoites can be lysed for protein study,
or for DNA and RNA extraction. They can also be used to infect confluent host cells in
EDI complete medium to transfer them into tachyzoites.
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CHAPTER 3
RESULTS

3.1 Transient knockdown of enolase expression
To investigate the function o f enolase isoforms in the development and stage
conversion o f T. gondii, we attenuated the expression o f these glycolytic enzymes using
RNAi approach. Initially, we conducted transient down-regulation assays o f E N O l and
E N 02 to evaluate the efficiency o f dsRNA induced silencing. In vitro synthesized dsRNA
homologous to E N O l and E N O l was electroporated into the parasites. The mock
electroporation was also performed using only electroporation buffer. Following the
electroporation (3-5 days), newly released parasites were collected to monitor the
expression o f EN O l and E N 0 2 using RT-PCR and western blot analysis. And ROP1
expression was used to establish the baselines for a comparison between different
electroporated parasite sets (Fig. 3.1 A, ROP1). We detected no change in mRNA level of
T. gondii ROP1 after electroporation with dsRNA homologous to E N O l, E N O l or GFP.
The E N 02 dsRNA electroporated parasites showed a decreased level o f E N 02 transcripts
~75 % (Fig. 3.1 A, E N 02) and contained un-modulated levels o f ROP1 and Argonaute
(Fig. 3.1 A, AGO), when these RT-PCR signals were compared with those o f the mock
electroporation. These results indicate that the dsRNA induced gene silencing is effective
to specifically lower the expression of EN O l.

69

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

To determine whether the transient gene knockdown affected the levels o f gene
products, western blot analysis was performed using polyclonal antibodies raised against
EN 02 and LDH1. We detected that EN 02 was decreased following the E N 0 2 dsRNA
electroporation (Fig. 3 .IB), but was not significantly affected by electroporation with
other dsRNAs. The signals revealed by LDH1 -antibody were used as loading controls for
the correction o f protein concentrations used in the study.
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Figure 3.1
T ransient down regulation of E N 0 2 expression
Legend

A.

Following dsRNA electroporations, total RNAs were isolated from T. gondii
strain RH and subjected to RT-PCR analysis using the oligonucleotide primers
specific to E N O l, ROP1 and AGO. The RNA samples used in the RT reaction
are also shown in the figure (right panel, not quantitative). The amount o f each
sample was quantified using spot densitometry of AlphaEase software.

B.

Western blots were incubated with polyclonal antibodies against EN 02 (upper
panel), and LDE11 (lower panel). The amount o f each sample was quantified
using spot densitometry o f AlphaEase software.
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Figure 3.1
Transient down regulation of E N 0 2 expression
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B. Western blot
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3.2 Generation of stable ENOl and E N 02 knockdown parasite lines
The results o f transient down-regulation confirmed the effectiveness and
specificity o f dsRNA induced silencing o f enolase expression. However the introduction
o f dsRNA into T. gondii can only produce transitory knockdown effects and is unsuitable
for the study o f their physiological functions. Therefore we created transgenic parasite
lines using RHAHX as parental parasites to obtain stably expression o f E N O l or E N 02
dsRNA to induce gene silecning.
The plasmids expressing dsRNA homologous to E N O l, E N 0 2 or GFP was
constructed by placing the target DNA fragment between two head-to-head promoters.
Such construction was previously used in the dsRNA expression in Trypanosoma
congolense, Trypanosoma brucei as well as T gondii (Bannai H et al., 2003; LaCount et
al., 2000; Al-Anouti et al., 2003). The plasmid construction was described in “Materials
and Methods” (Fig. 3.2).
The three constructed plasmids p(TUB 8 ) 2£vV(9 /-//A , p(T\JBS)2EN02-H X and
p(TUB 8 ) 2 GFP-HX were individually introduced into T. gondii strain RHAHX using
electroporation. Transformed parasites were then cultured using medium supplemented
with MPA and xanthine. The selection was maintained to ensure integration o f the
transforming plasmid into parasite genome. The stable transgenic parasite lines were
named as dsEN O l, dsEN 02 and dsGFP respectively, according to the transforming
plasmids used. We also tried to generate stable transgenic parasite lines using another
parental strain, named PLKAHX, which grow slower than RHAHX and can differentiate
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to bradyzoites more efficiently. Using such a strain, we aimed at dissecting the
knockdown effect influenced by different genetic makeup. Unfortunately we can only
obtain stable parasite line when p(TUB$)2EN02-HX was used, but not with other
constructs. This parasite line is named dsEN02P.
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Figure 3.2
Schematic representation of construction strategies
Legend
A. Plasmid used in the generation o f parasite lines with dsRNA expression. Two
tubulin promoters (Tub 8 ) are arranged head-to-head and the target gene
sequence (ENO l, E N 0 2 or GFP) is placed between these two promoters.
B. DNA fragments o f target genes cloned into the constructed plasmids.
Restriction sites for H indlll and Sacl are shown in E N O l and E N 02
fragments
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Figure 3.2
Scheme of constructed plasmids used to generate parasite lines
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3.3 Characterization of the transgenic parasite lines
To confirm the presence o f transgenes in the genome o f the parasites, total DNAs
of the transgenic parasite lines were extracted and subjected to PCR analysis for
comparison to the parental parasite strains. The expression o f dsRNA in the transgenic
parasite lines was monitored by RT-PCR.

3.3.1 Confirmation of transgene integration
To confirm that the ENOl or EN 02 transgenes were integrated into the parasite
genome, we made use o f the difference between the cDNA and genomic sequences. In
the gene encoding E N O l, there is a 493 bp intron separating the first 40 bp exon from the
rest o f the coding sequence, while E N 02 gene has a 650 bp intron. We synthesized the
oligonucleotide primers flanking these regions (5’ENOx and 3 ’ENOx). Using these
primers, we can easily distinguish the transgenic genes by their smaller size following
PCR amplification using isolated genomic DNA as templates and agarose gel
electrophoresis.
The results o f genomic PCR are shown in Figure 3.3. PCR using 5 ’ENOx and
VE N O x primers, a band o f ~1 kb was amplified from all samples, representing the
genomic locus o f E N O l gene. Additional bands o f approximately 540 bp, corresponding
to the transgenic gene o f EN O l or EN 02, were shown in the PCR products from genomic
DNA sample o f dsENO l and dsEN 02 strains (Fig. 3.3A lane 3, 4). Since the PCR
products o f EN O l and E N 02 transgenic DNA were similar in size, these PCR products
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were further analyzed by restriction endonuclease digestion to ensure the target genes
were properly amplified. For example, H indlll site is present in E N O l but not EN O l
gene. Thus H indlll can digest the PCR products derived from E N 02, but not those from
EN O l. Similarly, S a d will digest EN O l, but not E N 0 2 (Fig. 3.2B, C). The digestion
profile confirmed the identification o f the two -5 4 0 bp bands generated from the
transgenic strains, indicating correct integration o f transgene plasmid into the genome of
the parasites. Moreover, the genomic DNA samples were also subjected to the PCR
reaction using T7-5GFPmut2 and T7-3GFPmut2 primer set and the band representing the
GFP transgenic DNA was only generated from PCR using dsGFP gDNA as the template
(Fig. 3.3B), demonstrating the exclusive presence o f GFP transgene in the dsGFP strain.
The integration o f the transgene in the strain o f dsEN 02P was also confirmed by
genomic DNA PCR.
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Figure 3.3
Confirmation of transgene integration
Legend
A. Total DNA samples extracted from generated transgenic parasite lines and
parental strains were subjected to PCR to detect presence o f E N O l and E N 02
transgenes in parasite genome.
Lane 1: PCR products o f gDNA from parental strain RHAHX
Lane 2: PCR products o f gDNA from transgenic strain dsGFP
Lane 3: PCR products o f gDNA from transgenic strain dsENOl
Lane 4: PCR products o f gDNA from transgenic strain dsEN 02
Lane 5: DNA marker
B. Total DNAs extracted from generated transgenic parasite line dsGFP and
parental strains RHAHX were subjected to PCR to detect integration o f GFP
transgene in parasite genome. Constructed plasmid p(TUB 8 )2 G FP-H Z was
also used in PCR to serve as a positive control (+).
C. -5 4 0 bp PCR products from dsENOl and dsEN 02 genomic DNA were
subjected to S a d and H indlll digestion to confirm their identities.
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Figure 3.3
Confirmation of transgene integration

dsGFP

dsENOl
Sacl

550 bp

Hind\\\

+

dsEN02
Sacl

Hind\\\

*

250 bp— *

81

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

RHAHX

3.3.2 Expression o f dsRNA in the transgenic parasites
Investigation of dsRNA expression in the parasite lines is crucial. The constructed
plasmids used to generate these parasite lines were designed to express dsRNA
homologous to E N O l, E N 02 and GFP. Total RNA from the transgenic and parental
strains were extracted and used in RT-PCR analysis to detect the expression o f dsRNA
using 5’-ENOx and V-ENO x primer set as well as T7-5G/?jDmut2 and T7-3GFPmut2
primer set.
No significant band was produced in the RT-PCR using ENOx primer sets from
RNA samples isolated from parental strain RHAHX and the control strain dsGFP,
indicating that antisense RNA as well as dsRNA homologous to E N O l or E N 02 genes
was not expressed in these strains. When the total RNA samples from dsENOl and
dsEN 02 strains were used in the RT-PCR using ENOx primer sets, a band o f ~540 bp
was detected in both reactions (Fig. 3.4A, top panel). These two PCR products were also
subjected to restriction endonuclease digestion to verify their identities. The RT-PCR
band generated from dsENOl RNA can be digested by Sacl but not H indlll, indicating its
homology to E N O l gene, while the RT-PCR band obtained from dsEN 02 RNA can be
cut by H indlll but not Sacl, showing its E N 0 2 homology (Fig. 3.4B). These results
showed that dsRNA homologous to EN O l is only expressed in dsENOl strain, and
dsRNA homologous to E N 02 is exclusively expressed in dsEN 02 strain. The total RNA
samples from these four strains were also subjected to RT-PCR reaction using GFP
primer set, and positive results were only detected from dsGFP samples (Fig. 3.4A,
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middle panel), indicating that GFP dsRNA was only produced in this transgenic T. gondii
strain. Moreover, the expression o f dsRNA homologous to E N 0 2 in the transgenic strain
dsEN02Pwas also detected using the same method.
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Figure 3.4
Confirmation of dsRNA expression
Legend
A. Total RNA samples extracted from generated transgenic parasite lines
(dsENOl, dsEN02, dsGFP) and parental strains (RHAHX,) were subjected to
RT-PCR using ENOx (upper panel) and GFP (middle panel) specific primers
to detect dsRNA production. The RNA samples used in the RT reaction are
also shown in the figure (right panel, not quantitative).
B. -5 4 0 bp RT-PCR products from dsENOl and dsE N 02 total RNA were
subjected to Sacl and H indlll digestion to confirm their identities.

84

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Figure 3.4
Expression of dsRNA
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3.4 The steady state level of enolase transcripts in transgenic parasite strains
Our transforming plasmids were designed to express dsRNA that would trigger
gene silencing o f the target genes. Following the confirmation o f successful expression o f
dsRNA, we consequently evaluate whether the expressions o f the target genes are
knocked down. RT-PCR was used to assess the expression level o f these target genes.
Total RNAs were isolated from newly released tachyzoites o f the transgenic and parental
strains and used as templates in RT reaction in which the cDNA synthesis was initated
using oligodT as primers. Although oligodT priming might not give high yields as gene
specific primers do, it avoid variations among different RT reactions when the cDNA
products were used in gene-specific PCR amplification. The results o f the RT-PCR are
shown in Figure 3.5A, the identities o f the bands produced form ENOx RT-PCR is
confirmed by restriction endonuclease digestion, and the ratio o f E N 02/R 0P 1 signals
was also calculated for each sample. The expression level o f E N 0 2 was not changed in
the parental strain RHAHX, the control strain dsGFP as well as the transgenic strain
dsENOl (EN02/RO P1 ~l.O). In the strain dsEN 02, the ratio o f E N 02/R 0P 1 was ~0.4,
showing that the expression o f E N 0 2 was lowered in the level o f mRNA and indicating
that the knockdown effects induced by dsRNA was gene specific.

For the generated

strain dsEN02P, compared with the parental strain PLKAHX, similar results were also
observed (Fig. 3.5B). The expression level o f E N 0 2 mRNA in dsEN 02P strain was
lowered, but its ROP1 mRNA showed comparable amount with PLKAHX.
To measure the expression level o f gene products in the transgenic strains and the
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parental strain, western blot analysis was conducted utilizing polyclonal antibodies
against enolase isoforms ENOl and EN 02. Equal amounts (5 pg) o f protein extracts
from freshly lysed trachyzoites were resolved in SDS-PAGE gel and transferred to
nitrocellulose membrane. Figure 3.5C shows the results of the western blot. The lysate
from dsEN 02 strain contained less amount o f EN 02 protein. And no significant
difference o f EN 02 signal was detected in the control strain dsGFP, and the transgenic
strain dsENOl from the parental strain RHAHX (Fig. 3.5C, EN 02). Then, the membrane
was stripped and LDH1 signals were detect to confirm equal loading amount (Fig.3.5C,
LDH1). To further investigate whether EN O l, which is expressed in bradyzoite stage,
could compensate the loss o f EN 02 protein, an identical blot was prepared and incubated
with ENOl-specific antibody. Very faint signals o f ENOl were detected, suggesting that
this enolase isoform was not expressed to compensate attenuated E N 02 expression in
tachyzoite stage (Fig. 3.5C). The faint bands could result from cross-interaction o f EN 02
protein and EN O l - antibody.
Throughout the course o f this study, we found that the expression level o f EN 02
o f transgenic strain dsEN 02 was decreasing gradually following passages and selection
by MPA and xanthine (Fig. 3.5D). The ratio between EN 02 and LDH1 was ~1.6 after we
electroporated the constructed plasmid p(TUB 8 ) 2E N 02-H X into the parasites and passed
three times in HFF monolayers. The ratio decreased to -1.3 after six passages, and
become stable at the level o f -0 .6 after nine passages. We hypothesized that if this
observation was due to that a more homogenous population was formed following each

87

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

passage. Thus after RHAHX parasites were electroporated with p(TUB8)2£M92-HZ
plasmid and completely lysed the host cells, we used them to inoculate a 24-well plate
covered with HFF monolayers for cloning. About ten clonal parasites were acquired, five
o f which were used to infect new host cells and passed for three times before they were
analyzed by immunoblot. However, western blot results showed that, there was no
significant difference between the expression level o f EN 02 in those transgenic parasites
and that o f RHAHX.
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Figure 3.5
Gene expression in transgenic strains
Legend
A. Total RNA extracted from generated transgenic parasite lines (dsENOl,
dsEN 02, dsGFP) and parental strains (RHAHX) were subjected to RT-PCR to
detect ROP1 and E N 0 2 expression in mRNA level. The amount o f each
sample was quantified using spot densitometry o f AlphaEase software.
B. RNA extracted from generated transgenic parasite lines dsEN02P, and
parental strains PLKAHX were subjected to RT-PCR to detect ROP1 and
E N 0 2 expression in mRNA level.
C. Western blot analysis was performed using lysate extracted from tachyzoites
o f the transgenic parasite lines (dsEN O l, dsEN 02, dsGFP) as well as lysate
from the parental strains (RHAHX). The blot was treated with specific
polyclonal antibodies against EN 02 (upper panel) and EN O l (middle panel).
Anti-LDHl antibody was also used to confirm that comparable amount o f
sample were loaded (lower panel).
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Figure 3.5
Gene expression in transgenic strains
Legend (continue)

D. Western blot analysis showed the decreasing E N 02 expression level
dsEN 02 strains after transformation. LDH1 signals were also detected
normalize loading amount.
Lane 1: RHAHX
Lane 2: dsGFP
Lane 3: dsEN 02 after 11 passages
Lane 4: dsEN 02 after 9 passages
Lane 5: dsEN 02 after 6 passages
Lane 6: dsEN02 after 3 passages
Lane 7: dsENOl
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Figure. 3.5
Gene expression in transgenic strains
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C. Western blot
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LDH1

3.5 The localization of enolase
Immunofluorescence assay was performed to monitor the subcellular localization
o f enolase in the parental type strain RHAHX, as well as in the generated transgenic
strains. In addition to EN 02 (rhodamine-labeled secondary antibody) detection, we also
monitored the localization o f surface antigen 1 (SAG1 or P30), which is on the
membrane o f tachyzoites (Fluorescein isothiocyanate (FICT)-labeled secondary antibody,
green). Merging with nuclei stained (4’, 6 diamidino-2-phenylindole (DAPI), blue) image,
we detected that the EN 02 signal is localized in the cytosol and nuclei, similar to
previous report on the localization o f enolase (Fig. 3.6). In order to estimate the
expression level o f EN 02 protein, the intensity o f the fluorescence signal o f the parental
and transgenic tachyzoites were quantified and normalized with reference to the
background fluorescence signal. The ratio o f the EN 02 signals from the tachyzoite
parasite lines over those from the parental was calculated and plotted for each parasite
line. We detected that the EN 02 signal did not change significantly in the strain dsENOl
or dsGFP when compared to the parental RHAHX strain. However this signal was
attenuated in the strain dsEN 02, indicating the efficiency and specificity o f the dsRNA
induced enolase knockdown effects. Furthermore, in these transgenic parasite strains,
EN 02 signal was observed in both nucleus and cytosol o f the parasites, suggesting that
dsRNA induced RNAi does not affect the localization o f EN 02 protein.
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Figure 3.6
Localization of E N 0 2
Legend
A. Parasites o f Parental strain RHAHX and transgenic strain dsEN 02 are
subjected to immunofluorescence assay. DAPI was used to label the nucleus
of parasites (blue). FITC-labeled goat anti-mouse IgG was used to show the
SAG1 localized on the membrane o f T. gondii (green). Rodamine-labeled goat
anti-rabbit IgG was used to reveal the localization o f E N 0 2 (Red).
B. Normalized fluorescence values o f E N 02 signals for the parasite lines under
tachyzoite culture conditions.
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Figure 3.6
Localization of E N 02
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dsEN02

3.6 Phenotypic analysis o f transgenic parasite strains
We would expect that the knockdown o f enolase might affect the growth o f T.
gondii. The multiplication rates o f the transgenic strains as well as the parental strain
were thus monitored. Since T. gondii proliferates by a synchronic unique binary division,
the number o f parasites per vacuole could reflect the division rate. Following trypan blue
staining to evaluate the parasite viability, we used 10,000 viable parasites o f each strain,
including dsEN O l, dsEN 02 and RHAHX, to infect confluent HFF monolayers. The
parasites were allowed to invade the host cells for 1 hour, and then non-attached or dead
parasites were removed by rinsing with fresh media. At 24 hours and 48 hours
post-infection, we counted the numbers o f parasites within independent vacuoles
(between 150 - 200 vacuoles) The fractions o f vacuoles containing 1-, 2-, 4-, 8-, 16 or 2"
parasites were caculated in order for comparing the growth distribution o f tested parasite
strains as shown in Figure 3.7. There was no significant difference between the transgenic
strains dsEN O l, dsEN 02 and the parental strain RHAHX, indicating that the suppression
of expression o f ENOl and E N 02, two isoforms of enolase, did not affect the growth o f T.
gondii, at least in the stage o f tachyzoite.
Plaque formation assay was also employed to monitor the overall proliferation
ability o f the generated transgenic strains dsEN O l, dsEN 02, dsGFP as well as the
parental strain RHAHX. Approximately 5,000 viable parasites were used in the infection
o f HFF monolayers. After changing the medium at 1 hour post-infection, the cells were
incubated in tachyzoite culture condition for; 6 days. The plates were stained and the
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number and sizes o f plaques were monitored. No significant differences in the numbers and
sizes o f formed plaques were detected in the transgenic strains dsENOl

(68

formed

plaques), dsEN 02 (73 formed plaques) when compared with the parental strain RHAHX
(77 formed plaques). This result further verified that inhibition o f enolase expression does
not reduce the growth and proliferation ability o f T. gondii, at least in the RH strain.
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Figure 3.7
Parasite growth and replication
Legend
The fraction distribution o f vacuole size (number of parasites in each vacuole) was
determined at 24 hours (A) and 48 hours (B) after infection with the parental and
transgenic parasite lines grown under tachyzoite culture conditions. About 150 vacuoles
were counted for each strain at 24-hour time point, and about 200 were counted at
48-hour. The expression o f EN 02 and LDH1 o f the strains used at that time point were
shown by western blot (C).
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Figure 3.7
Parasite growth and replication
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CHAPTER 4
DISCUSSION

Enolase is one o f the essential enzymes in the processes o f both glycolysis and
gluconeogenesis. In T. gondii, the stage-specific expression pattern o f two isoforms of
enolase (EN O l and EN 02), suggests that the activity and effectiveness o f this enzyme
are important for the tachyzoite and bradyzoite. Stage differentiation and encystation o f T.
gondii involves the coordinated expression o f several genes. A series o f induction and
suppression o f gene expression are observed during the process as developmental
dynamics. It is not surprising to propose the involvement o f enolase expression in the
process o f stage differentiation between tachyzoite and bradyzoite. Although classical
nuclear localization signal is not found in ENOl and EN 02 primary sequences, their
nuclear targeting can be enabled by a NLS in their tertiary structures (Sessler and Noy
2005), or be mediated by importin-independent pathways (Gorlich and Kutay, 1999).
Nuclear localization o f ENOl and E N 02 proteins suggests other functions such as
regulation o f gene expression o f this enzyme in addition to its contribution to the
metabolism o f the parasites (Johnstone et al., 1992;Ghosh et al., 1999). Thus, study on
the function o f this enzyme, particularly silencing o f its expression, would be o f great
interest and be important to provide potential drug targets for the treatment to
toxoplasmosis.
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Transient transformation and silencing of enolase
Previous studies by our group have confirmed that dsRNA can be used as a
powerful tool to repress the steady-level expression o f T. gondii genes including UPRT
and LD H (Al-Anouti et al., 2003; Al-Anouti et al., 2004). We first used dsRNA
homologous to EN O l and E N 02 genes to silence the expression o f enolase in T. gondii.
From RT-PCR and western blot analysis, I clearly demonstrated the efficiency and
specificity o f synthetic dsRNA in down-regulating enolase expression. Silencing of
E N 02 did not affect to the expression o f EN O l and GFP, and vice versa. Although, we
did not determine whether siRNA was produced, we suspect that siRNA produced from
dsRNA can function as miRNA and can inhibit expression of non-perfect-matching genes
in translational level (Doench et al., 2003). Both siRNA and miRNA gene silencing
pathway share similar partners such RNaselll (Dicer) and Argonaute family proteins and
are likely to be present in T. gondii, although miRNA pathway has not been reported in T.
gondii. Though we cannot state definitely that miRNA as well as siRNA is responsible
for the gene silencing, we can conclude that the difference between E N O l and E N 0 2 is
sufficient (65.8%) to obtain specific gene silencing.

Stable transformation and transgenic line generation
To circumvent the disadvantage o f transient transformation, we used constructed
plasmids and T. gondii strain RHAHX to generate transgenic parasite lines. We also
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attempted to generate the transgenic parasites lines using PLKAHX. We could not
produce the lines, except one expressing E N 0 2 homologous dsRNA, naming dsEN02P.
Parasite strains RHAHX, PLKAHX are different in growth and replication rate. Failure to
generate transgenic parasites lines expressing ENOl homologous dsRNA might be due to
the slow proliferation ability o f the PLKAHX strain, which renders the electroporated
parasites hard to propagate under selection. Another possibility is the transformation
stability o f this plasmid is low in PLKAHX strain, or the expression o f EN O l is important
for the growth o f PLKAHX strain.
We also found that, the expression o f EN 02 in the dsEN 02 parasites was gradually
lowered during parasite passages and became stable at -40% o f the steady state level of
the untransformed parasites. One o f the possibilities is that the expression o f dsRNA was
increasing after transformed plasmid stably integrated into parasite genome, leading to
the increasing inhibition o f target gene expression induced by dsRNA. It is also possible
that, after plasmid transformation, untransformed parasites and those with unstable
transformation were able to survive under selection at first, but were killed gradually
under selection pressure. We attempted to purify the transformed parasites by limiting
dilution, but all five single clonal strains did not show any E N 02 knockdown after three
passages. Probably more passages o f the transformed parasites would be required to
enhance the dsRNA inhibition effects. Monitoring the amount o f dsRNA expressed by
quantitative real-time RT-PCR may provide useful information about this question.
PCR using DNA extracted from transgenic parasite lines showed the presence of
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transgenes in these generated cell lines. However, it was difficult to distinguish whether
these transgenes were integrated into the genome or maintained as episomes. To have
clear evidences o f plasmid integration or episomal maintenance, we need to perform a
plasmid rescue experiment. Briefly we would extract total DNA from the parasites and
use it to transform competent E. coli cells. Only episomal DNA will have the
transforming plasmid

features to confer ampicillin resistance.

Also, restriction

endonuclease digestion followed by Southern blot analysis would address this question.

Phenotypic study of enolase knockdown
The ratio o f vacuoles containing different numbers o f T. gondii in total vacuoles
showed the proliferation ability o f the parasites, and plaque assay reflected both invasion
ability and proliferate ability. Results o f both methods indicated knockdown o f EN 02
expression does not affect the growth o f the parasites. As the glycolysis is considered to
be important for the growth and development o f T. gondii, and enolase is an essential part
of glycolysis process, these results are quite surprising to some degree. One o f the
possibilities is that T. gondii has plenty amount o f E N 02 expression, and the lefeover
EN 02 in dsEN 02 strain is sufficient for the survival o f the parasites. Gene targeting of
EN 02 gene by homologous recombination (knockout or knockin) or expression of
inactive E N 02 to produce dominant-negative mutant may help to resolve the role of
EN 02 in T. gondii. It is also possible that other genes, enzymes or metabolic pathways
have taken over to compensate for the reduction o f EN 02 expression. To have a global

105

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

view o f the gene expression, we need to perform microarrays to classify affected genes.
Moreover, we could use metabolic inhibitors, specific to the enzymes o f the glycolysis
pathway to survey the drug sensitivity in the parental and transgenic parasites. Other
metabolism pathways, including TCA cycle and anaerobic respiration may provide
required NADH and subsequent ATP for the survival o f the parasites when glycolysis is
suppressed. Additionally, fatty acids and amino acids can be oxidized to produce
acetyl-CoA, pyruvate and other metabolites required in these processes instead of
glycolysis pathway. Inhibition o f these pathways may provide adequate insight into the
metabolism system o f the transgenic parasites and put forward essential information for
this study.

Future work
In this study, we used dsRNA-induced gene silencing to lower the expression of
enolase isoforms, EN O l and EN 02 in Toxoplasma gondii. Two transgenic parasite lines
with attenuated enolase expression dsENOl and dsEN02 were successfully generated.
We found that, although EN 02 expression was reduced, it did not affect the growth
ability o f T. gondii strain RH. Future work could be directed to study the effects of
enolase knockdown in the stage o f bradyzoite as well as the process o f stage conversion.
Moreover, we would like to investigate the reason for unaffected growth o f T. gondii with
lowered enolase expression. Inhibitors o f Krebs cycle and anaerobic respiration as well as
fatty acid and amino acid oxidation pathway will be used to elucidate the possible
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pathway utilized by the parasites to compensate the suppression o f glycolysis.
Additionally, extra roles o f T. gondii enolase isoforms will be another target o f upcoming
study. Protein and chromatin immunoprecipitation can provide useful information about
proteins and DNA bound with enolase in the nuclei, and grant essential information about
the functions o f enolase.
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APPENDICES

Appendix I
General buffers and solutions used in the study

Constituents

Buffer or solution
Blocking solution for western blot

5 g slim milk powder in 100 ml TBS
120 mM M KC1, 0.15 mM CaCl2, 10 mM

Electroporation buffer

K 2 HPO 4 /KH 2 PO 4 , pH 7.6, 25 mM HEPES,
pH 7.6, 2 mM EDTA, 5 mM MgCl2

TBS

125 mM NaCl, 25 mM Tris

TBST

0.2% Tween 20 in TBS

6

x DNA gel loading buffer

0.25% (w/v) bromophenl blue, 0.25% (w/v)
xylene cyanol FF, and 40% (w/v) sucrose in
water

Dulbecco’s phosphate-buffered saline

PBS buffer supplemented with 0.1 g/1 Ca+2

(DPBS)
Luri Bertani broth (LB broth)

10 g/1 tryptone, 5 g/1 yeast extract and, 0.17
M NaCl. The broth is sterilized by
autoclaving for 15 min.

Tris EDTA (TE)

10 mM Tris, pH 8.0, and 1 mM EDTA

Tris-Acetate-EDTA (TAE)

40 m Tris-acetate and 1 mM EDTA
0.14 M NaCl, 2.7 mM KC1, 10 mM

Phosphate-buffered saline (PBS)

Na 2H P 0 4 and 1.76 mM KH 2 P 0 4 KH 2P 0 4,
pH 7.4
9% acrylamide/bisacrylamide (37.5:1), 0.39
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M Tris, pH

SDS-PAGE Resolving gel

8 .8

, 0.1% SDS, 0.1% APS and

0.04% TEMED
5%

acrylamide/bisacrylamide

(37.5:1),

0.125 M Tris, pH 6 .8 , 0.1% SDS, 0.1% APS

SDS-PAGE Stacking gel

and 0.1% TEMED
25mM

SDS-PAGE loading

Tris, pH

Bromophenol
2

6 .8

, 2%

Blue,

-mercaptoethanol and

10%

SDS,

0.1%

720

mM

glycerol

25 mM Tris, pH 8.3, 196 mM glycine and

Tris-glycine

0.1% SDS
25

Transfer buffer for western blot

mM

Tris,

192 mM

glycine,

20%

methonal
300 mM NaCl, 20 mM Tris-HCl, 1 mM

Protein Lysis buffer

DTT, 0.5 mM PMSF, pH7.5,
Genomic DNA extraction buffer

100 mM EDTA, 10 mM Tris-HCl, pH 8.0
and 1% SDS

Miniprep solution I

50 mM glucose, 25 mM Tris-HCl, pH 8.0

Miniprep solution II

0.2 N NaOH, 1% SDS

Miniprep solution III

3 M NaOAc, pH 5.2

Ponceau Staining solution

0.1% ponceau in 5% acetic acid solution
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A ppendix II
Oligonucleotide prim ers used in the study

Names

Sequences

BamHI 5' pTUB 8

CCGGATCCGTCGACGGTATCGATAAGC

N sil 3’pTUB8

CTCATGC ATTTTGTCG

H XGPRT forward

ATGGCGTCCAAACCCATTGAA

HXG PRT reverse

ACCGGTGTCGACGTCCTC

5'HXcassatte

CCAGAATTCAAGATCCGATCTTGC

3 ’HXcassette

CCAGAATTCTGTCACTGTAGCCTG

5 ’ENOx

ATGGTGGTTATCAAGG

3 'ENOx

CCAACGGGAGCGATC

EcoRITgArg5'end

T GG A ATTCCCCGC AGTATTT CGC A A ATG

EcoRIT g Arg3 'end

CGGAATTCGCTTCGCCACTGAGGTGAG

OligodT

TTTTTTTTTTTTTTTTTT

EcoRIdTTAIL

AAGAATTCTTTTTTTTTTTTTTTTTT

llo n X E N O x

TAATACGACTCACTATAGGATGGTGGTTATCAAGG

T7on3 ’ENOx

TAATACGACTCACTATAGGCCAACGGGAGCGATC

llo n y R O P

TAATACGACTCACTATAGGGGAACATGGGCCACAGG

llo n V R O P

TAATACGACTCACTATAGGCGCCGAAAGCGTCTCTG

T7-5GFPmut2

AAGAATTCTAATACGACTCACTATAGGAGAAGAACTTTCAC

T7-3GFPmut2

AAG A ATT CTAATACG ACT C ACTATAGGTCT GCTAATT G AA
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Appendix III
Nucleotide sequence of constructed plasmids used in the study

All the

constructed plasmids were

generated from

commercial plasmid

pBluescript SK+. The primers used for each DNA fragments are indicated by arrows.

Kpnl

A m picillih R e s is ta n c e il>l«v

Tul>8 p io m o te i

HXGPRT
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p(TUB8)2EN 01-H X
The TUB 8 promoter as well as followed E N O l DNA fragment and the opposite
TUB 8 promoter were used to replace 653-719nt (Kpnl-BamHT) o f pBluescript SK+. And
HXGPRT expression cassette was inserted at the SacII site (747 nt) o f pBluescript SK+.

Nucleotide sequence o f TUB 8 promoter (515bp)

Kpnl
GGTACCGGGC CCCCCCTCGA CGGTTATCGA TAAGCTTAAC CACAAACCTT
GAGACGCGTG TTCCAACCAC GCACCCTGAC ACGCGTGTTC CAACCACGCA
CCCTGAGACA CATGTTCTAA CCACGCACCC TGAGACGCGT GTTCTAACCA
CGCACCCTGA GACGCGTGTT CAAGCTTGCC TGCATTGGGT GCGGTTGGTG
ATCCTGGTTG GACCGGTGGA GATGCGCGCG CACGAAGGGG ATGTGTCAGA
AACATTTTGT TTGTTCTCTG TGAACTTTTA GATGTGTTAA AGGAGGAGAA
TATTAGCAGA GAGTCCTCCT TGTTCCATTC TCTCTTGAAT TTCGCCCTTT
CCTTCTCTTT GCGAGTGTGG TAGAGAACAA GCACTCGTTC GCCGTCCCTG
ACGACGCAAC CCGCGCAGAA GATCCACCAA ACGGTGTTAC ACAATCACCT
TGTGTGAAGT TCTTGCGGAA AACTACTCGT TGGCATTTTT TCTTGAATTC
CCTTTTTCG A CAAAA

Nucleotide sequence o f E N O l fragment (542bp)

ATGGTGGTTA TCAAGGACAT CGTTGCACGC GAGATTTTGG ATTCTCGCGG
CAATCCCACA ATTGAAGTTG ATGTATCAAC TGAAGGAGGT GTCTTCCGAG
CTGCGGTTCC TAGTGGAGCG TCTACGGGTA TTTATGAGGC TCTGGAGTTG
CGCGATAAAG ATCCGAAACG GTACTTGGGG AAAGGCGTGC TGAACGCTGT
AGAGATTGTC CGACAGGAAA TCAAGCCAGC ATTGCTGGGC AAAGATCCGT
GTGATCAGAA AGGTATTGAT ATGCTTATGG TGGAGCAGCT GGACGGAACA
AAAAACGAGT GGGGCTATTC CAAGTCAAAG CTAGGTGCAA ATGCCATTTT
GGGCGTGTCG ATAGCTTGCT GCCGAGCAGG AGCAGCATCA AAAGGCCTAC
CACTATACAA ATACATCGCT ACACTTGCAG GGAAAACGAT CGATAAGATG
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GTTATGCCTG TACCGTTTTT CAATGTTATC AATGGAGGCG AACATGCAGG
CAATGGCTTG GCTCTTCAAG AATTCCTGAT CGCTCCCGTT GG

Nucleotide sequence o f reverse TUB 8 promoter (505bp)

TTTTGTCGAA AAAGGGAATT CAAGAAAAAA TGCCAACGAG TAGTTTTCCG
CAAGAACTTC ACACAAGGTG ATTGTGTAAC ACCGTTTGGT GGATCTTCTG
CGCGGGTTGC GTCGTCAGGG ACGGCGAACG AGTGCTTGTT CTCTACCAC
ACCGCAAAGA GAAGGAAAGG GCGAAATTCA AGAGAGAATG GAACAAGGAG
GACTCTCTGC TAATATTCTC CTCCTTTAAC ACATCTAAAA GTTCACAGAG
AACAAACAAA ATGTTTCTGA CACATCCCCT TCGTGCGCGC GCATCTCCAC
CGGTCCAACC AGGATCACCA ACCGCACCCA ATGCAGGCAA GCTTGAACAC
GCGTCTCAGG GTGCGTGGTT AGAACACGCG TCTCAGGGTG CGTGGTTAGA
ACATGTGTCT CAGGGTGCGT GGTTGGAACA CGCGTGTCAG GGTGCGTGGT
TGGAACACGC GTCTCAAGGT TTGTGGTTAA GCTTATCGAT AACCGTCGAC
GGATCC
BamHl

Nucleotide sequence o f HXGPRT Cassette (1889 bp)

SucH
CCGCGGAAGA TCCGATCTTG CTGCTGTTCG CGTCCCAGTA GCGTCCTGTC
GGCCGCGCCG TCTCTGTTGG TGGGCAGCCQ CTACACCTGT TATCTGACTG
CCGTGCGCGA AAATGACGCC ATTTTTGGGA AAATCGGGGA ACTTCATTCT
TTAAAAGTAT GCGGAGGTTT CCTTTTTCTT CTGTTCGTTT CTTTTTCTCG
GGTTTGATAA DCGTGTTCGA TGTAAGCACT TTCCGTCTCT CCTCCGTGCT
TTGTTCGACA TCGAGACCAG GTGTGCAGAT CCTTCGCTTG TCGATCCGGA
GACGCGTGTC TCGTAGAACC TTTTCATTTT ACCAACGGCA GTGCGGAGCA
CTGCTCTGAG TGCAGCAGGG ACGGGTGAAG TTTCGCTTTA GTAGTGCGTT
TCTGCTCTAC GGGGCGTTGT CAGATCCAAA ATGGCGTCCA AACCCATTGA
AGACTACGCC AAGGGCAACG GCCGTATTGA GCCCATGTAT ATCCCCGAGA
ACACCTTCTA GAACGCTCAT GACTTTCTTG TGCCCCCCCA CTGCAAGCCC
TACATTGACA AAATCCTCCT CCCTCGTGGA TTGGTCAAGG AGAGAGTTGA
GAAGTTGGCG TATGACATCC ACAGAACTTA GTTCGGCGAG GAGTTGCACA
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TCATTTGCAT CCTGAAAGGC TCTCGCGGCT TCTTCAACCT TCTGATCGAG
TACCTTGCCA CCATACAGAA GTAGAATGGT CGTGAGTCCA GCGTGCCCCC
CTTCTTCGAG CACTATGTCC CCCTGAAGTC CTACCAGAAC GACAACAGCA
CAGGCCAGCT TACCGTCTTG AGCGACGACT TGTCAATCTT TCGCGACAAG
CACGTTCTGA TTGTTGAGGA GATCGTCGAG ACCGGTTTCA ACCTCACCGA
GTTCGGTGAG CGCCTGAAAG CCGTCGGTCC CAAGTCGATG AGAATCGCCA
CCCTCCTCGA GAAGCGCACA GATCGCTCCA ACAGCTTGAA GCCGGCCGAG
TTCGTCGGCT TCAGCATTGA AGAGGTCTGG ATCGTTGGTT GCTGCTACGA
CTTCAACGAG ATGTTCCGCG ACTTCGAGCA CGTCGCCGTC CTGAGCGACG
CCGCTCGCAA AAAGTTCGAG AAGTAAACCC TGCATAGCCC TACAGAAGCT
GCCCGTCTCT CGTTTTCCTC TCTTTTCGGA GGGATCAGGG AGAGTGCCTC
GGQTCGGAGA GAGCTGACGA GGGGGTGCCA GAGACCCCTG TGTCCTTTAT
CGAAGAAAAG GGATGACTCT TCATGTGGCA TTTCACACAG TCTCACCTCG
CCTTGTTTTC TTTTTGTCAA TCAGAACGAA AGCGAGTTGC GGGTGACGCA
GATGTGCGTG TATCCACTCG TGAATGCGTT ATCGTTCTGT ATGCCGCTAG
AGTGCTGGAC TGTTGCTGTC TGCCCACGAC AGCAGCCAAC TTTCCTTCTA
TGCACTTGCA GGATGGTGCA GCGCAAACGA CGGAGAGAAA GGAGCACCCT
CTCAGTTTCC CTACGATGTG CTGTCAGTTT CGACTCTTCA CCGCGAACGA
TTGGCGATAC GTCTCTGTTG ACTTGTTAGG CTCCGACCAC GAAGCTCCCT
T AACT A A AT A AGCCGCGACA CCTAAGTGTA CACCATTTGC AGATCGATAA
TCTGCGACCG CTGAATCCGT CCAGATCAGT AAAACCGCAC CACCTAAGTG
TAAACCTTGT TTAGGTCGAT AAAATGCTAC CAACCCCCAC CCACAATCGA
GCCTTGAGCG TTTCTGCGCA CGCGTTGGCC TACGTGACTT GCTGATGCCT
GCCTCTGGCC ATTCATCCAG TCAGTGCGCA TAAAAATGTG GACACAGTCC
GGTTGACAAG TGTTCTGGCA GGCTACAGTG ACACCGCGG
Sacll
p(TUB8)2£7\0 2 -H X
Similar to p lT U B ^ E N O J -H X except E N O l fragment replaced by E N 0 2 fragment.
Nucleotide sequence o f EN 02 fragment (542bp)

ATGGTGGCCA TCAAGGACAT
AAACCCGACC GTCGAGGTTG
CCGCTGTCCC CAGCGGCGCA
CGTGACAAGG ACCAAACTAA
GGAGAACATC CACAAGATTA
GCGACCAGAA GGGTATTGAC
AAGAACGAGT GGGGCTGGTG

CACTGCTCGT CAGATCCTCG ACTCCCGAGG
ACTTGTTGAC CGATGGCGGC TGCTTCCGTG
TCCACTGGCA TCTACGAGGC GCTTGAGCTC
GTTCATGGGC AAGGGTGTGA TGAAGGCCGT
TCAAGCCGGC GCTTATTGGC AAGGACCCGT
AAGCTGATGG TCGAGGAGCT CGATGGAACT
CAAGTCGAAG CTCGGCGCGA ACGCGATCCT
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GGCCGTCTCG
CCCTGTACAA
GTAATGCCCG
CAACAAGGTC

ATGGCTTGCT
GTACATTGCC
TCCCGTTCTT
GCGATGCAGG

GCCGCGCCGG CGCTGCTGCC AAGGGCATGC
ACTTTGGCTG GAAACCCGAC AGACAAGATG
CAACGTCATC AACGGCGGCT CCCACGCAGG
AGTTCATGAT CGCCCCCGTC GG

p(TUB8)2GFP-lZX
Similar to p(7\JB8)2EN 01-H Xexcept E N O l fragment replaced by GFP fragment.
Nucleotide sequence o f GFP fragment (533bp)

A G G A G A A G A A CTTTTCACTG GAGTTGTCCC AATTCTTGTT GAATTAGATG
GCGATGTTAA TGGGCAAAAA TTCTCTGTCA GTGGAGAGGG TGAAGGTGAT
GCAACATACG GAAAACTTAC CCTTAAATTT ATTTGCACTA CTGGGAAGCT
ACCTGTTCCA TGGCCAACAC TTGTCACTAC TTTCGCGTAT GGTCTTCAAT
GCTTTGCGAG ATACCCAGAT CATATGAAAC AGCATGACTT TTTCAAGAGT
GCCATGCCCG AAGGTTATGT ACAGGAAAGA ACTATATTTT ACAAAGATGA
CGGGAACTAC AAGACACGTG CTGAAGTCAA GTTTGAAGGT GATACCCTTG
TTAATAGAAT CGAGTTAAAA GGTATTGATT TTAAAGAAGA TGGAAACATT
CTTGGACACA A A ATGG A ATA CAACTATAAC TCACATAATG TATACATCAT
GGCAGACAAA CCAAAGAATG GAATCAAAGT TAACTTCAAA ATTAGACACA
ACATTAAAGA TGGAAGCGTT CAATTAGCAG ACC
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Appendix IV
Nucleotide sequence of other constructed plasmids

All the constructed plasmids were

generated

from

commercial plasmid

pBluescript SK+. The primers for each DNA fragment are indicated by arrows.

Kpnl

Tiil>8tet4 T i ib 5tet7 |>i om otei \

EcoRI

Ai <jon»nite

T ubStetJ |>i om otei
HX Cos s err e

S.ICll

pT8t4ArgoT8t4-.HX

The TUB8tet4 promoter as well as followed Argonaute DNA fragment and the
opposite TUB8tet4 promoter were used to replace 653-719nt (Kpril-BamHl) of
pBluescript SK+. And HXGPRT expression cassette was inserted at the SacII site (747 nt)
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o f pBluescript SK+.

Nucleotide sequence o f Tub8tet4 promoter (598 bp)
Kpnl
GGTACCGGGC CCCCCCTCGA CGGTATCGAT AAGCTTAACC ACAAACCTTG
AGACGCGTGT TCCAACCACG CACCCTGACA CGCGTGTTCC AACCACGCAC
CCTGAGACGC GTGTTCTAAC CACGCACCCT GAGACGCGTG TTCTAACCAC
GCACCCTGAG ACGCGTGTTC AAGCTTGCCT GCATTGGGTG CGGTTGGTGA
TCCTGGTTGG ACCGGTGGAG ATGCGCGCGC ACGAAGGGGA TGTGTCAGAT
CCCTATCAGT GATAGAGACT CGAGTCTATC ACTGATAGGG ATGTCGAGTC
TATCACTGAT AGGGATGTCG AGTCTATCAC TGATAGGGAT GTCGAGAACA
TTTTGTTTGT TCTCTGTGAA CTTTTAGATG TGTTAAAGGC GGCGAATATT
AGCAGAGAGT CCTCCTTGTT CCATTCTCTC TTGAATTTCG CCCTTTCCTT
CTCTTTGCGA GTGTGGTAGA GAACAAGCAC TCGTTCGCCG TCCCTGACGA
CGCAACCCGC GCAGAAGACA TCCACCAAAC GGTGTTACAC AATCACCTTG
TGTGAAGTTC TTGCGGAAAA CTACTCGTTG < GCATTTTTTC TTGAATTC
EcoRI
Nucleotide sequence o f Argonaute DNA fragment (861 bp)

CCCGCAGTAT TTCGCAAATG TTATGTCCAA AGTCAACATG AAGTTGCAAG
GAGTGAATCA AACCCTCGAG GCGGATATAA TAAAGCAAGA AATCGGAACG
GACAAGAGCA CATTGGTCTT GGCGGTAGAA ACATCATTCT TTGCAAATCC
GACTAAAACT TCTCCCCCGC CGACAGCGCC CATTGTGTGT GCGTGTACGG
GAAACATGGA CGATGATCTT GGCGCGTTCG GTCATGCTGT TTGCGTTGAA
TCGCGAAAGC ATCCCATAGT GACTGATATT GGGAGTATGT TTAAAACTAT
TCTCTCCTAT CGAAAGACAA CGAAAAACTG GCCGGCGCGA ATCATCTACC
TTCGATCTGC CACTACAGAA GCACACTTCC CTCTTGTATT GGCCGGCGAA
ATCCGTGCGA TCGAAGAATT ATATGTTCGT GAAAACCGTT CAAAACCTCG
AATCCTCGCC GTAGCAGTGC AAAGGCGACA GCAAACACGT TTATTCCCTA
CGAAGGAGAT GCAGGCTCAG GGAAACAATC TGCCAGCAGG GTTCTTGCTT
GCGAATAGTC TGCAACATCC AGGGCACTTC CGAAATTTCT TGTTGATCTC
ACACAAAGCA CTCCAGGGAA CAGCGCGCCC AACAAGGTAT TACATTTTAA
GAGACGATGC GAACCGCGAC ATGG A A A AAG TTGCCCAGCT GATGTACTCT
CTGTGCCATG TGTACGGTCG CTGCCAGCGA GCGGTCTCCA TTCCCGCTCC
CCTGTACTAC GCCGAGCTGC TGGCGGCAAG AGCTCAAAGC TACATGAAGG
TTGGCATGCG TAGAGAAAGA AATATAGATA TTGACGATCT TTCTCACCTC
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AGTGGCGAAGC

Nucleotide sequence o f Reverse Tub8tet4 promoter (589 bp)

EcoRI
GAATTCAAGA AAAAATGCCA ACGAGTAGTT TTCCGCAAGA ACTTCACACA
AGGTGATTGT GTAACACCGT TTGGTGGATG TCTTCTGCGC GGGTTGCGTC
GTCAGGGACG GCGAACGAGT GCTTGTTCTC TACCACACTC GCAAAGAGAA
GGAAAGGGCG AAATTCAAGA GAGAATGGAA CAAGGAGGAC TCTCTGCTAA
TATTCGCCGC CTTTAACACA TCTAAAAGTT CACAGAGAAC AAACAAAATG
TTCTCGACAT CCCTATCAGT GATAGACTCG ACATCCCTAT CAGTGATAGA
CTCGACATCC CTATCAGTGA TAGACTCGAG TCTCTATCAC TGATAGGGAT
CTGACACATC CCCTTCGTGC GCGCGCATCT CCACCGGTCC AACCAGGATC
ACCAACCGCA CCCAATGCAG GCAAGCTTGA ACACGCGTCT CAGGGTGCGT
GGTTAGAACA CGCGTCTCAG GGTGCGTGGT TAGAACACGC GTCTCAGGGT
GCGTGGTTGG AACACGCGTG TCAGGGTGCG TGGTTGGAAC ACGCGTCTCA
AGGTTTGTGG TTAAGCTTAT CGATACCGTC GACGGATCC
BamHl
^ T S tlA rg o T m -H X
Similar to pT8t4^rgoT8t4-//A except first Tub8tet4 promoter replaced by Tub5tet7
promoter.

Nucleotide sequence o f Tub5tet7 (682bp)
Kpnl
GGTACCGGTC GACGGTATCG ATAAAGCTTG ATGGCGATGC
TTCGTGAAAT TCTCTGCATC AGCGGAGTGA TCAGGAATCA
GGGATGACGT TGCGGAGCAG GCCGGCTCGC GGTGGGCAGT
AGGCGTAACT CAGGACGGCT TGCGCTCATC GCAGAACAGG
GCATTGGGTG CGGTTGGTGA TCCTGGTTGG ACCGGTGGAG
ACGAAGGGGA TGTGTCAGAT CCCTATCAGT GATAGAGACT
ACTGATAGGG ATGTCGAGTC TATCACTGAT AGGGATGTCG

ATGTCCCGCG
TCGTCTCAGC
CAGATGCCGA
GGTGGTGCCT
ATGCGCGCGC
CGAGTCTATC
AGTCTATCAC

129

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

TGATAGGGAT GTCGAGTCTA TCACTGATAG
ATAGGGATGT CGAGTCTATC ACTGATAGGG
GTTCTCTGTG AACTTTTAGA TGTGTTAAAG
GTCCTCCTTG TTGGATTCTC TCTTGAATTT
GAGTCTCGTA GAGAACAAGC ACTCGTTCGC
GCGCAGAAGA CATCCACCAA ACGGTGTTAC
TCTTGCGGAA AACTACTCGT TGGCATTTTT

GGATGTCGAG TCTATCACTG
ATGTCGAGAA CATTTTGTTT
GCGGCGAATA TTAGCAGAGA
CGCCCTTTCC TTCTCTTTGC
CGTCCCTGAC GACGCAACCC
ACAATCACCT TGTGTGAAGT
TCTTGAATTC
EcoRI

K|>nl

Tul>8tet4Tiil>5tet7 pi omotei
EcoRI

Tul>8tet4 |»i omotei
EcoRI

CAT

l>30 11 pi omotei

N s il

pT8t4^r^oT8t4-p30/HC47’
The TUB8tet4 promoter as well as followed Argonaute DNA fragment and the opposite
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TUB8tet4 promoter were placed next to Kpnl (653 nt) of pBluescript SK+. And CAT
expression cassette (p30/ll promoter + CAT gene + p30 3’UTR) was inserted before
BamHl site (719 nt) o f pBluescript SK+.

Nucleotide sequence o f p3 0/11 promoter (518bp)

CTCGAGGTCG
TTCCAACCAC
CGTGTTCTAA
GACGCGTGTT
GCACCCTGAC
CCACGCACCC
CTGCCGCACA
CTGTTCTCGG
CGTTGTGCAG
TGTAAACACA
TCTGGTTTTT

ACGGTATCGA
GCACCCTGAC
CCACGCACCC
CAAGCTTAAC
ACGCGTGTTC
TGAGACGCGT
ATGTGCECCT
CAAGGGCCGA
CTTTCCGTTC
CGGTTGTATG
TGACGAGT

TAAGCTTAAC CACAAACCTT GAGACGCGTG
ACGCGTGTTC CAACCACGCA CCCTGAGACG
TGAGACGCGT GTTCTAACCA CGCACCCTGA
CACAAACCTT GAGACGCGTG TTCCAACCAC
CAACCACGCA CCCTGAGACG CGTGTTCTAA
GTTCTAACCA CGCACCCTGA GACGCGTGTT
GTAGGAAGCT GTAGTCACTG CTGATTCTCA
CGACCGGAGT ACAGTTTTTG TGGGCAGAGC
TTCTCGGTTG TGTCACATGT GTCATTGTCG
TCGGTTTCGC TGCACCACTT CATTATTTCT

Nucleotide sequence o f CAT gene (697bp)
Nsil
ATGCATGAGA
CCATCGTAAA
ATAACCAGAC
AAAAATAAGC
CATGAATGCT
TGATATGGGA
GAAACGTTTT
TCTACACATA
ATTTCCCTAA
TGGGTGAGTT
CTTCGCCCCC

A A A A A ATC AC TGGATATACC ACCGTTOATA TATCCCAATC
GAACATTTTG AGGCATTTCA GTCAGTTGCT CAATGTACCT
CGTTCAGCTC GATATTACGG CCTTTTTAAA GACCGTAAAG
ACAAGTTTTA TCCGGCCTTT ATTCACATTC TTGCCCGCCT
CATCCGGAAT TCCGTATGGC AATGAAAGAC GGTGAGCTGG
TAGTGTTCAC CCTTGTTACA CCGTTTTCCA TGAGCAAACT
CATCGCTCTG GAGTGAATAC CACGACGATT TCCGGCAGTT
TATTCGCAAG ATGTGGCGTO TTACGGTGAA AACCTGGCCT
AGGGTTTATT GAGAATATGT TTTTCGTCTC AGCCAATCCC
TCACCAGTTT TGATTTAAAC GTGGCCAATA TGGACAACTT
GTTTTCACCA TGGGCAAATA TTATACGCAA GGCGACAAGG
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TGCTGATGCC GCTGGCGATT CAGGTTCATC ATGCCGTCTG TGATGGCTTC
CATGTCGGCA GAATGCTTAA TGAATTACAA CAGTACTGCG ATGAGTGGCA
GGGCGGGGCT TAATTAA
Pad
Nucleotide sequence o f p30 3 ’UTR (317)

TCACCGTTGT GCTCACTTCT CAAATCGACA AAGGAAACAC
GCATGTGCCC CATTATAAAG AAACTGAGTT GTTCCGCTGT
TGTCACATCC ACAAAAACCG GCCGACTCTA AATAGGAGTG
AGCAGCGAAG TTTATGACTG GGTCCGAATC TCTGAACGGA
ACCTGGCTGA TGTTGATCGC CGTCGACACA CGCGCCACAT
ACAAGACAGC TATCAGTTGT TTTAGTCGAA CCGGTTAACA
CCCCCCGAGG GGGATCC
BamH

ACTTCGTGCA
GGCTTGCAGG
TTTCGCAGCA
TGTGTGGCGG
GGGTCAATAC
CAATTCTTGC

pT5t7/4rg0T8t4-p3O/llC47’
Similar to pT 8t44rgoT 8t4-p30/llC 4r except first Tub8tet4 promoter replaced by
Tub5tet7 promoter.
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